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ABSTRACT 
 
 
Introduction. Total hip arthroplasty (THA) surgery is one of the most commonly 
performed and successful orthopedic procedures in the United States. More than 300,000 
primary THAs and 40,000 revision THAs performed in the United States every year. 
While the need for revision surgeries can stem from a variety of causes, there have been, 
to the author’s knowledge, no studies attempting to correlate the concentrations of certain 
inflammatory cytokines to metal ion concentrations found in the tissue surrounding the 
implant, amount of polyethylene wear, or strength of the interface of the modular taper. 
The purpose of this study was to begin to look at those factors to see if any were 
indicative of implant survivorship, as well as to see if metal ion content contributes to 
implant longevity. The testing for this group of well-functioning implants will be useful 
as a baseline when comparing the same types of testing for failed implants. 
 
Methods. A total of nineteen cadaveric total hip implants were obtained from two 
sources, the Medical Education and Research Institute (Memphis, TN) and 
RestoreLifeUSA (Elizabethton, TN). The bearings for these implants were either metal 
on polyethylene or ceramic on polyethylene. Synovial fluid and tissue samples were 
taken from the joint for testing. Head dissociation was performed, in which an Instron 
4505 was used in accordance with ASTM Standard F2009-00 to remove the head from 
the stem of the implant, recording force. Corrosion scoring was performed on taper 
surfaces by three scorers. The polyethylene acetabular liner was measured on the superior 
side with a micrometer to determine how much material loss was evident compared to the 
inferior side. These three values were then correlated to the testing performed using the 
synovial fluid and tissue. The synovial fluid was analyzed for inflammatory cytokines IL-
6, MCP-1, IL-1β, MIP-3α, M-CSF, IL-8, IL-2, and TNF-α using a premixed Luminex 
screening assay. These results were given in picograms per milliliter. An anterior and 
posterior synovial tissue sample was analyzed for the presence of metal ions cobalt, 
chromium, and titanium using Inductively Coupled Plasma Mass Spectrometry (ICP-
MS). All of these results were compiled and analyzed together to search for potential 
correlations.  
 
Results. There were no significant differences in dissociation forces between the groups 
of implants with head corrosion score 1 and head corrosion score 2. The comparison of 
MCP-1 to the dissociation force produced a correlation coefficient of 0.64 (p-value 0.05) 
and the comparison of MIP-3α to the dissociation force produced a correlation coefficient 
of 0.67 (p-value 0.03). However, when the graphs of these correlations were observed, it 
seemed likely that this correlation was due to one sample pulling the graph in a positive 
direction which is demonstrated by the 95% confidence interval (CI) of the correlation 
coefficient (0.011 to 0.90 for MCP-1, and 0.069 to 0.91 for MIP-3α). When comparing 
polyethylene wear to the inflammatory cytokine concentrations, no significant 
correlations were seen. There was a positive correlation between cobalt and chromium 
levels and dissociation force (r=0.56 for cobalt, r=0.66 for chromium), and a negative 
correlation between titanium levels and dissociation force (r=-0.30). The positive 
relationship was opposite of what was expected, as more metal debris should mean the 
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implant surfaces are losing material, which should therefore decrease the strength of the 
taper connection. The 95% confidence interval for the correlation coefficients included 
zero for cobalt and titanium, and was fairly wide for chromium (0.11 to 0.90). When 
observing cytokines and metal ion presence, most relationships were very scattered with 
low correlation coefficients. However, for cobalt, strong positive relationships were seen 
for IL-6 (r=0.67, CI: 0.19 to 0.89), MCP-1 (r=0.76, CI: 0.33 to 0.93), and MIP-3α 
(r=0.60, CI: 0.066 to 0.86). When looking at confidence intervals, there seemed to be a 
mild correlation between cobalt and IL-6 and a moderate correlation between cobalt and 
MCP-1. No meaningful relationships were seen for any cytokines with chromium or 
titanium, so it may be useful to select cytokines known to be responsive to those two 
metals in particular for future studies. When comparing metal levels between the two 
corrosion levels seen in the heads, there were no statistically significant differences in 
any of the metals between implants with a corrosion score of one and those with a 
corrosion score of two.  
 
Discussion. This study was limited by the fact that the sample size for this study was very 
low. With only nineteen total implants, it was difficult to draw meaningful conclusions. 
Additional implants are being recruited in order to increase this sample size for future 
studies. Additionally, it was difficult for meaningful correlations to be seen when 
comparing any factor to the inflammatory cytokine concentrations, as these values were 
clustered around the lower limit of detection. However, this was expected with well-
functioning implants. While it is difficult to draw meaningful conclusions when used as a 
correlation, this data will be useful when comparing cytokine concentrations of a group 
of failed implants. This group is able to serve as a baseline value for each type of testing 
performed, and will help to make sense of the same testing of failed implants in the 
future.  
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CHAPTER 1.    INTRODUCTION 
 
 
Significance of Research 
 
 Total hip arthroplasty (THA) surgery is one of the most commonly performed and 
successful orthopedic procedures in the United States [1]. The first THA in the United 
States was performed in 1960, and currently more than 300,000 THAs are performed in 
the United States every year [2]. While many of these operations are successful, there are 
almost 40,000 revision THAs performed in the United States annually as well. This 
number has been steadily rising over the last twenty years, and is predicted to continue to 
do so, making it a growing problem. The average hospital charge for a revision THA is 
$54,600 [3]. These revision surgeries can be due to a variety of causes, but so far there 
have been no studies attempting to correlate the concentrations of certain inflammatory 
cytokines to metal ion concentrations found in the tissue surrounding the implant, amount 
of polyethylene wear, or strength of the interface of the modular taper. The purpose of 
this study was to begin to look at those factors to see if any potential biomarkers could be 
identified as indicative of implant survivorship, as well as if metal ion content contributes 
to implant longevity. The testing for this group of well-functioning implants (implanted 
at time of death) will be useful as a baseline when comparing the same types of testing 
for failed implants.  
 
 
Relevant Anatomy 
 
 The hip joint is one of the largest joints in the human body, comprised of the 
femur and acetabulum. It is considered to be a ball-and-socket joint, in which the ball is 
the femoral head and the socket is the acetabulum of the pelvis. The femur is the only 
bone in the upper leg, while the acetabulum is a deep, semispherical socket cavity in the 
hip located at the convergence of the ilium, ischium, and pubis (Figure 1-1). The 
acetabulum is where the femoral head articulates during hip motion.  
 
A THA may be necessary because of a variety of causes, but one of the most 
common causes is osteoarthritis, where the cartilage that typically cushions the joint is 
worn away. When the cartilage is worn away, the femoral head and acetabulum directly 
articulate against one another, causing pain and stiffness. Osteoarthritis accounts for 70% 
of THA cases [1]. Another frequent cause of hip pain can be post-traumatic arthritis, 
which occurs when an injury to the hip causes the cartilage to become damaged, and 
therefore, stiffness and pain occur. Trauma can lead to articular cartilage loss, 
incongruency, or cartilage damage which can then lead to painful joint articulation, 
resulting in the need for a total hip arthroplasty. Rheumatoid arthritis, aseptic necrosis, or 
the presence of a tumor are other factors that can be indicative of the need for a total hip 
replacement [4].   
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Figure 1-1. Ball and socket joint of the hip 
 
Reprinted with permission.  
Foran, J.R.H. Total Hip Replacement. OrthoInfo 2015 8/2015 [cited 2016 8/18/16]. 
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Total Hip Arthroplasty 
 
 
Surgical Procedure 
 
 A THA is performed by an orthopedic surgeon, and can be done with either an 
anterior or posterior approach. The implant used for a THA has several components: a 
femoral stem which goes into the femur, a femoral head which is placed onto the stem via 
an impaction, the acetabular shell which sits in the reamed acetabulum, and the 
polyethylene liner which fits in the shell and is the articulating surface for the femoral 
head (Figure 1-2).  
 
 The two most popular surgical approaches used in THA are the posterolateral 
approach and the direct anterior approach [5]. For the posterolateral approach, the patient 
is first anchored in a lateral decubitus position. An incision is then made that is centered 
over the greater trochanter and is curved posteriorly, beginning at a point level with the 
anterior superior iliac spine. The incision is then extended distally to the center of the 
greater trochanter along the femoral shaft, and to a point ten centimeters distally from the 
greater trochanter. The subcutaneous tissues are dissected and the gluteus maximus is 
split in the direction of its fibers. The fascia is dissected away from the fibers of the 
gluteus medius, and a Charnley or other self-retaining retractor is inserted beneath the 
fascia lata at the level of the trochanter, ensuring the sciatic nerve is not entrapped 
beneath the retractor. The external rotators are divided as closely to the femur as possible, 
and the rotators are reflected posteriorly to protect the sciatic nerve. The interval between 
the gluteus minimus and superior capsule are bluntly dissected. Hohmann retractors are 
placed superiorly and inferiorly to obtain exposure of the entire capsule. The capsule is 
divided adjacent to its femoral attachment and preserved for later repair. A Steinmann pin 
is inserted into the ilium superiorly to the acetabulum to determine leg length. The hip is 
then dislocated posteriorly by flexing, adducting, and gently internally rotating the hip, 
and the head is lifted out of the acetabulum with a bone hook. The bony margins of the 
rim of the acetabulum are exposed to facilitate proper placement of the acetabular 
component, and any osteophytes that protrude beyond the bony limits of the acetabulum 
are removed. The acetabular component, and later, the femoral component, are then 
implanted as described in the following paragraphs [5].  
 
The direct anterior approach requires less muscular dissection than the posterior 
approach, and is done with the patient in the supine position. A skin incision is placed 
lateral to the interval between the tensor fascia latae and sartorius to avoid injury to the 
fibers of the lateral femoral cutaneous nerve, which may be variable in its course. The 
fascia is divided over the muscle belly of the tensor fascia latae fibers to stay lateral to the 
lateral femoral cutaneous nerve. The interval between the tensor fascia latae and the 
sartorius is bluntly dissected with an index finger so that the femoral neck can be 
palpated through a thin layer of fat overlying the anterior capsule. Blunt curved retractors 
are placed superior and inferior to the femoral neck, taking care in the placement of the 
retractor beneath the rectus femoris to avoid injury to the femoral nerve and vessels. The 
anterior hip capsule is divided into a T or H shape for later repair. An in situ osteotomy is  
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Figure 1-2. Components of total hip prosthesis  
 
Reprinted with permission. 
Foran, J.R.H. Total Hip Replacement. OrthoInfo 2015 8/2015 [cited 2016 8/18/16]. 
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performed of the femoral neck and the femoral head is extracted with a corkscrew. The 
acetabulum is then exposed by placing curved retractors distal to the transverse 
acetabular ligament and along the posterior rim of the acetabulum to displace the femur 
posteriorly. The proximal femur is exposed by placing the operated limb in a figure-of-
four position and adducting the femur slightly while externally rotating 90 degrees. The 
femur is elevated laterally and upward with a bone hook, taking care not to trap the femur 
behind the acetabulum. Often, additional soft-tissue release is needed at this stage to 
avoid excess retraction force. The acetabulum and femur are then prepared and 
components are implanted as described in the next paragraph [5].  
 
The acetabulum is prepared by excising the ligamentum teres and any remaining 
soft tissue. The floor of the acetabulum is palpated, and the acetabulum is prepared with 
reamers, going from smaller to larger reamers in the direction of the opening face of the 
acetabulum. Reaming is complete when all cartilage has been removed, the reamers have 
cut bone out to the periphery of the acetabulum, and a hemispherical shape has been 
produced. When inserting the acetabular cup, the surgeon ensures the patient is in a true 
lateral position to avoid the cup being placed in a retroverted position. The acetabular 
component that is the same size as the last reamer can then be implanted with fixation, or 
a slightly oversized component (1 to 2 mm) can be press-fit for more initial stability. The 
acetabular component is attached to the positioning device which is used to ensure the 
proper angle of inclination and anteversion is obtained. Once the correct position has 
been determined, the acetabular component can be impacted until there is intimate 
contact between the implant and the bone. Screws may be used for ancillary fixation, 
preferably in the posterosuperior quadrant. Once screws are implanted, the stability of the 
component is tested, looking for no detectable movement between the implant and bone. 
Once this is complete, the polyethylene liner can be implanted, ensuring that no soft 
tissue is interposed between the liner and its metal backing, as this can interfere with the 
locking mechanism. Next, to prepare the femur, a laparotomy sponge is placed in the 
acetabulum to protect the component. The proximal femur is exposed by internally 
rotating the femur so the tibia is perpendicular to the floor. A retractor is used to deliver 
the proximal femur, and any remaining soft tissue is excised from the neck. A box 
osteotome can be used to remove any remaining portions of the lateral aspect of the 
femoral neck and medial portion of the greater trochanter to allow access to the center of 
the femoral canal. Once the femur is exposed, a small reamer is inserted slightly posterior 
and lateral on the cut surface of the femoral neck. The reamer is aimed down toward the 
medial femoral condyle and is progressed to the appropriate depth. This continues with 
progressively larger reamers until diaphyseal cortical reaming is felt. The proximal 
portion of the femur is prepared by removing residual cancellous bone along the medial 
aspect of the neck with precision broaches. The broach is placed in the same alignment as 
the axial reamers and the handle is pushed laterally during insertion to ensure enough 
lateral bone is removed and to avoid varus positioning of the stem. The broach can be 
rotated to control anteversion. From the posterior approach, the medial aspect of the 
broach must be rotated toward the floor. Progressively larger broaches are used, 
maintaining identical alignment and rotation. The final broach is seated where it is axially 
stable within the canal with the cutting teeth at or below the level of the preliminary neck 
cut. The fit of the broach within the canal is assessed, and when adequate stability has 
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been obtained the final adjustment of the neck cut is made. The final level of the neck cut 
should correspond with the measured distance above the lesser trochanter established in 
preoperative templating. The trial neck component is selected and impacted, and the 
center of the femoral head is evaluated with radiographs. The hip is moved through a 
range of motion, noting any areas of impingement between the femur and pelvis or 
between the prosthetic components. If the stability is acceptable, the hip is redislocated 
and the head is lifted out of the acetabulum. The trial components and broach can then be 
removed, and the appropriately sized femoral component can be gently impacted down 
the canal. An audible change in pitch can be detected as the stem nears final seating. The 
stability of the stem is assessed when exposed to rotational and extraction forces. If 
satisfactory, the debris are wiped from the Morse taper and the segment is dried and the 
prosthetic head is affixed to the neck with a single blow over a plastic-capped head 
impactor. The stability is again confirmed through a full range of motion, and if 
satisfactory, the patient can be closed [5]. 
 
 
Design History 
 
The earliest recorded attempt at a hip replacement surgery was in Germany in 
1891 [6]. The methodology and results were presented at the 10th International Medical 
Conference by Professor Themistocles Glück. In his method, ivory was used to replace 
the femoral heads for patients in which tuberculosis had destroyed their hip joints. Later, 
in the late 19th and early 20th centuries, surgeons tried interpositional arthroplasty in 
which various tissues (fascia lata, skin) were placed between articulating hip surfaces for 
arthritic hips [6]. In 1925, Marius Smith-Petersen created the first mold arthroplasty made 
of glass. His design featured a hollow hemisphere to fit over the femoral head to provide 
a smooth surface for movement. Although glass is biocompatible, it was not able to 
withstand the forces the hip joint experiences and shattered. The same surgeon later went 
on to try stainless steel and created the first total hip replacement that was fitted to bone 
with bolts and screws [9]. In 1953, George McKee was the first to regularly use a metal-
on-metal prosthesis [7]. He began by using a modified Thompson stem, which was a 
cemented hemiarthroplasty used in femur neck fracture treatment, with a cobalt-chrome 
socket for the acetabulum. One study showed a 28 year survival rate of 74% for this 
method, but by the mid-1970s this method became unpopular due to local effects of metal 
particles seen in revision surgeries for failure [9]. Sir John Charnley is considered to be 
the father of the modern THA [8]. He created a low friction arthroplasty in the early 
1960s which consisted of three parts: a metal femoral stem, a polyethylene acetabular 
component, and acrylic bone cement. This is very similar in principle to many of the 
designs being used today [9]. 
 
 
Current Design 
 
 During typical gait, the human hip is placed under cyclic loading in which it is 
subjected to forces that are three to five times the force of body weight [1]. This force can 
increase up to twelve times body weight for more strenuous activities, such as running or 
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climbing [1]. Therefore, the design of a hip implant must be able to be subjected to this 
excess loading over many cycles without wearing down, while still approximating the 
normal motion of the natural hip joint. Most of the acetabular cup portions of these 
implants consist of a metal alloy lined with ultrahigh molecular weight polyethylene. 
These acetabular components are not typically cemented, but they can be. The acetabular 
cups can also be created with an outer porous metal shell in which bone can grow into. 
Previous designs did not have the polyethylene component between the acetabular cup 
and the femoral head, but the two metal components articulating with one another created 
high friction, resulting in metallic wear debris and then loosening of the implants as well 
as pseudotumors, therefore, a polyethylene liner is now typically used between the 
acetabular shell and femoral head [10]. As for the femoral component, it is typically 
made of metal such as stainless steel, titanium, or cobalt-chromium in order to ensure 
long-term resistance to breakdown from loading [1]. Titanium alloys are frequently used 
in hip stems and other bone-contacting components because of their good bone-ingrowth 
qualities, and high strength. Titanium alloys may not be as useful in bearing components, 
because they have a higher wear rate. Cobalt-chromium-molybdenum (CoCrMo) alloys 
are frequently used in these articulating components because of their high wear 
resistance, but they do not have as good osteointegration qualities so they are less-
frequently used in the bone contacting components [10].   
 
A design feature that is common in all modern total hip replacements is a 
modular, Morse-like taper between the neck and head. The neck component is typically 
part of the stem, unless a second modular taper is used between the stem and neck, 
therefore making the neck its own separate piece. Designs have moved away from the 
dual-taper system, however, due to higher risk of wear and metallic debris. The taper 
consists of the male portion, called the trunnion, and the female portion, called the bore 
[11]. With the head-neck modular taper, the head is fixed to the neck potion by an 
interference fit, where the surgeon applies one impaction to the head in order to secure it. 
This modularity allows the surgeon to have many options in regards to designing an 
implant specific to the patient. It allows for different materials to be combined, specific 
head sizes to be used, and allows the surgeon to control leg length through neck offset. 
The strength of the connection between the neck and head is dependent on the taper 
design, the impaction force, and the condition of the taper surfaces [12].  
 
 In the trunnion portion of the taper, there are varying design parameters that differ 
depending on the type of implant being used. The bore portion of the taper must be 
designed to fit the trunnion, so it is mostly dependent on the trunnion design used. These 
two parts are not interchangeable between different manufacturers or implant designs, 
they are created to be placed together. The characteristics that can vary with the trunnion 
are the taper angle (2α), the diameters of the proximal and distal portions, the 
engagement length, and the head-neck offset (Figure 1-3). Typical top (D1) and bottom 
(D2) diameters used are 12/14 mm, 11/13 mm, 9/10 mm, and so on. These dimensions 
are disclosed by companies, however, most consider the taper angles to be proprietary 
and will not disclose the specific angles. The taper angles are typically only a few 
degrees. The engagement length, L, is the axial length of the taper that makes contact 
across the junction. While each of these factors can play a role in implant design, there 
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Figure 1-3. Schematic drawing of taper geometry 
 
Reprinted with permission. 
Gilbert, J., S. Mali, and S. Sivan, Corrosion of Modular Tapers in Total Joint 
Replacements: A Critical Assessment of Design, Materials, Surface Structure, 
Mechanics, Electrochemistry, and Biology, in Modularity and Tapers in Total Joint 
Replacement Devices. 2015, ASTM International. 
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are also differences in how the materials are processed. For example, manufacturers may 
vary the roughness of the surfaces using purposefully machined microgrooves or micro-
ridges. These ridged or microgrooved geometries are typically used to accommodate 
ceramic heads in order to avoid overloading the ceramic and thus decreasing the potential 
for burst fracture. Another variation in taper design is the head-neck offset. These can 
change depending on what best fits the needs of the patient, and refers to the position of 
the center of the head component and the most proximal taper trunnion position. The 
ability to vary head-neck offset is necessary in order to limit joint laxity, restore leg 
length, and for acetabular and femoral rotation center alignment [10].  
 
 
Current Materials Used in Bearing Articulation 
 
 
Metal on Polyethylene 
 
 Metal-on-polyethylene bearings are the most commonly used today, and provide a 
safe, predictable, and cost-effective bearing for the majority of patients [13]. This 
particular design features a metal stem and metal acetabular cup, with a polyethylene 
liner on the inside of the acetabular cup (Figure 1-4). The main concern with this type of 
material is polyethylene debris, as when the body encounters this debris the macrophages 
secrete inflammatory cytokines which can be mediators of bone lysis and can lead to 
aseptic loosening and eventually, implant failure. The presence of these debris can be 
minimized with the irradiation of polyethylene with gamma particles [9]. 
 
 
Metal on Metal 
 
 Metal-on-metal bearings fell out of favor in the 1970s due to concerns of the 
bearings producing metal ions, leading to metallosis and in severe cases, pseudotumors, 
but came back into production in the late 1980s through the early 2000s. A problem that 
may occur from metal on metal bearings is possible hypersensitivity reactions and 
loosening of the implant [7]. Patients receiving this type of implant also tend to have 
cobalt and chromium ion blood levels that are three to five times higher than those seen 
in patients with metal on polyethylene prostheses (Figure 1-5) [9]. However, this may 
not be true if there is excessive mechanically assisted crevice corrosion between the 
cobalt chromium head and stem of a metal on polyethylene bearing. In these instances, 
the metal on polyethylene bearing may exhibit similar increased metal levels to metal on 
metal [10]. 
 
 
Ceramic on Ceramic 
 
 Half of the THAs performed in central Europe use ceramic heads, but in the UK 
and USA this rate drops to less than ten percent. Implants using these materials were 
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Figure 1-4. Cup portion of metal-on-polyethylene prosthesis  
 
Reprinted with permission. 
Knight, S.R., R. Aujla, and S.P. Biswas, Total hip arthroplasty–over 100 years of 
operative history. Orthopedic reviews, 2011. 3(2): p. 16. 
 
 
 
 
 
 
Figure 1-5. Metal on metal total hip prosthesis  
 
Reprinted with permission. 
Knight, S.R., R. Aujla, and S.P. Biswas, Total hip arthroplasty–over 100 years of 
operative history. Orthopedic reviews, 2011. 3(2): p. 16. 
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designed to address to problems of friction and wear reported with other materials [13]. 
This design is typically a ceramic head on a metal stem, and a ceramic lining in the 
acetabular cup (Figure 1-6). The ceramic used typically consists of either alumina or 
zirconia. The benefits of ceramic-on-ceramic bearings include the high level of hardness, 
scratch resistance, and the inert nature of debris. These prostheses have also been shown 
to have improved lubrication, lowering the coefficient of friction and improving wear 
resistance. These are often a good choice for young, active patients. Excellent surgical 
technique is needed with this type of implant, because chipping of the contact surface 
with insertion of the prosthesis or dislocation are possible and can lead to third body wear 
[9].  
 
 
Ceramic on Polyethylene 
 
 Ceramic-on-polyethylene bearings are one of the most popular bearing types used 
today[14, 15]. This particular design features a metal femoral stem with a ceramic 
femoral head and a polyethylene liner on the inside of the acetabular cup. Similar to 
metal on polyethylene, one major concern with these materials is the generation of 
polyethylene debris. When the body encounters this debris, the macrophages secrete 
inflammatory cytokines which can be mediators of bone lysis and can lead to aseptic 
loosening and eventually, implant failure. The presence of these debris can be minimized 
with the irradiation of polyethylene with gamma particles [9]. Another risk with using 
ceramics in total joint replacements is the risk of a burst fracture occurring. If there is any 
defect in the material upon implantation, that can lead to failure of the femoral head. The 
femoral head can also experience a burst fracture if it receives a strong impact, such as 
experienced in car accidents. In cases of burst fracture, the implant must be revised. 
However, regardless of this potential failure mechanism, this type of bearing is frequently 
used in THAs because of its strong performance history. This type of bearing also 
eliminates the production of metallic debris from the taper connection, as this connection 
is now a ceramic with a metal instead of a metal on a metal.   
 
 
American Society for Testing and Materials (ASTM) Standards for Testing of 
Bearing Materials 
 
 Each of the bearing materials mentioned above goes through a series of testing 
before being implemented as a material used in total joint replacements. ASTM Standard 
F732-00 provides a test method for evaluating the wear properties of combinations of 
materials that are being considered for use in bearing surfaces of total joint prostheses. It 
describes various tests to quickly and reliably screen material combinations for wear 
performance in different orthopedic wear applications prior to beginning joint simulator 
testing. The recommendations from this standard describe test methods to evaluate the 
friction and wear properties of materials being considered in bearing surfaces for total hip  
replacement. The standard provides a baseline of wear quantities per year clinically for 
the results of the testing to be compared to (69 ± 33 mm3 per year for 22 mm heads, 85± 
33 mm3 per year for 28 mm heads, and 90 ± 44 mm3 per year for 32 mm heads). It also  
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Figure 1-6. Ceramic on ceramic total hip prosthesis 
 
Reprinted with permission. 
Knight, S.R., R. Aujla, and S.P. Biswas, Total hip arthroplasty–over 100 years of 
operative history. Orthopedic reviews, 2011. 3(2): p. 16. 
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provides a wear method of 7 mm3 per million cycles for ultra high molecular weight  
polyethylene (UHMWPE). The standard also defines how to prepare the polymer 
specimen and the counterface, as well as the specifications for the wear machine. The 
standard allows for load to be variable as long as it correlates to existing contact stresses. 
It also specifies that motion between the specimen and counterface must be 
multidirectional to achieve wear rates and wear mechanisms that are representative of 
those in a fixed-bearing ball-cup application, and recommends the system includes a 
cycle counter and strain gauge to measure friction. This standard is consistently used in 
the development and testing for new bearing materials, and has already been completed 
for the bearing materials used in total hip replacements discussed previously [16].  
 
 
Taper Wear 
 
 One problem that is evident at the taper component of hip implants is 
Mechanically Assisted Crevice Corrosion (MACC). MACC is a process in which 
mechanical wear or deformation affects the alloy surface electrochemically. The 
contributing factors to MACC are varied and include material and mechanical factors, 
transport factors, solution chemistry inside and outside of the taper, electrochemical 
factors, and biological factors [10]. This type of corrosion is also frequently called 
fretting corrosion and is seen very commonly in retrieval analysis of devices using the 
Morse- type taper. A study done by Gilbert showed that 16 to 35 percent of 148 retrieved 
total hip implants had signs of moderate to severe corrosion at the head-neck taper 
connection [10]. Some of these implants consisted of a Ti-6Al-4V-alloy stem and a 
cobalt-alloy head, and some consisted of both a cobalt-alloy stem and neck. Based on a 
literature review, the prevalence of MACC ranges from 10 to 100% of retrieval 
specimens, each with varying degrees of damage. The damage amount is dependent on 
alloy composition, femoral head diameter, implantation time, and physical and 
mechanical factors [11].  
 
The alloys used in the taper connection have oxide films that form on them that 
are a few nanometers thick. These oxide films give the alloys their corrosion resistance 
and serve as kinetic barriers to help keep corrosion rates low [17]. They have the ability 
to repassivate, or self-heal, in milliseconds if the conditions are favorable. However, the 
crevices found in the taper portion of the implant are typically at a higher risk of stress 
and micromotion which necessitates constant repassivation of the oxide layer, causing 
loss of oxygen and leading to a lower pH, high chloride content, and more negative 
potentials. These conditions can prevent the oxide films from self-healing, which can 
allow for the release of cobalt and chromium ions. Additionally, the formation of oxides 
(Cr2O3 and CoO) leads to a continuation of the oxide layer being unable to heal and can 
cause more oxides and ions to be released [10].  
 
Disassembly testing has been done to determine how assembly procedure and 
material combination can affect the disassembly force of a modular total hip implant. A 
study by Rehmer found that disassembly forces were directly related to the assembly 
forces [18]. It also found that multiple impactions during assembly did not increase the 
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taper strength [18]. Although this finding is interesting, the study discussed in this thesis 
did not know the impaction force of the received implants, so therefore one cannot say 
whether the disassembly forces are due to the taper conditions or assembly forces and 
thus, must just be taken as a stand-alone force value. 
 
 
ASTM Standard for Determining the Axial Disassembly Force of Taper 
Connections 
 
 ASTM Standard F2009-00 was created in order to establish a standard 
methodology for determining the force required to disassemble tapers of implants that are 
otherwise not intended to release. This method is used primarily for evaluation of metal 
and ceramic head designs and provides a means to measure the axial locking strength of 
the taper connections. For this testing, the cone portion of the assembly should be 
constrained by suitable features, and the modular head should be disassembled with a 
cage that provides even contact around the inferior edge of the head. The testing machine 
should deliver a tensile force at a constant displacement, and should have load monitoring 
and recording. For the disassembly, special care should be taken to ensure no artificial 
hoop stresses or bending moments are placed on the taper assembly, and a displacement 
rate of 0.05 mm/s should be used. The load and displacement should be recorded 
continuously until the test is complete [19]. 
 
 
Inflammatory Cytokines 
 
 With THA being as widely performed an operation as it is, a focus has been 
placed on periprosthetic osteolysis and aseptic loosening, because both of these factors 
can cause loosening of the implant, and therefore, failure. Metal debris from THAs can 
stimulate the production of polymorphonuclear leukocytes and macrophages locally, 
which can lead to a foreign body chronic inflammatory reaction [20]. When looking at 
the soft tissue around loose prostheses, there is often a foreign body reaction because of 
polyethylene, metal, or polymethylmethacrylate (PMMA) particles. Macrophages, 
lymphocytes, and other immune cells are activated when wear debris are introduced into 
the tissue, and these can secrete inflammatory cytokines such as interleukins, 
chemokines, interferons, and tumor necrosis factors in response to these debris. 
 
 There are several cytokines known to be involved in macrophage activation via T-
cells. Macrophages are phagocytic cells that are found in tissues or as mobile white blood 
cells, especially at infection sites. The cytokines that are known to do this are interferon-
gamma (IFN-gamma) and interleukin-2 (IL-2) [21]. These have each been shown in the 
literature to be present during macrophage activation. Another category of cytokines is 
those present in inflammation. These have been well-documented in literature and 
include tumor necrosis factor alpha (TNF-α), macrophage colony stimulating factor (M-
CSF), granulocyte macrophage colony stimulating factor (GM-CSF), interleukin-1-beta 
(IL-1β), interleukin-6 (IL-6), and monocyte chemotactic protein-1 (MCP-1) [22, 23]. 
These have each been shown to be present at times of inflammation, specifically 
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associated with orthopedic implants. Chemokines are a final category of cytokines 
present and relevant in the loosening of THA devices. These function in attracting white 
blood cells to sites of infection. The well-known chemokines found in literature to be 
relevant in metal orthopedic implants with loosening are interleukin-8 (IL-8), 
macrophage inflammatory protein-1-alpha (MIP-1α), eotaxin, and macrophage 
inflammatory protein-3-alpha (MIP-3α) [24].  
 
Each of these classes of cytokines play a role in the inflammation and potentially 
result in aseptic loosening, which is why the concentrations of each of these will be 
measured in the synovial fluid of each retrieved device. The kits used for the 
inflammatory cytokine testing were purchased from R&D Systems (Minneapolis, MN). 
The kits purchased allowed us to test for TNF- α, M-CSF, IL-1 β, IL-6, CCL2/MCP-1, 
IL-2, CXCL8/IL-8, and MIP-3 α. These eight cytokines were targeted because they are 
known to play a role in the inflammatory process. TNF-α and IL-1β were the first 
cytokines shown to stimulate bone resorption in vitro, so these cytokines were identified 
early as cytokines of interest when studying total joint replacements. One study compared 
the synovial levels of TNF-α and IL-1β in patients with loosened prostheses, fixed 
prostheses, and osteoarthritis controls [25]. A difference was found in these levels 
between loosened and osteoarthritis groups, but not loosened and fixed implants. IL-6 
and IL-8 were selected because of their roles in the inflammatory process as well. IL-6 is 
secreted by osteoblasts to induce osteoclast formation and can act as either a pro-
inflammatory or anti-inflammatory cytokine. IL-8 is a chemokine released by peri-
implant cells such as macrophages, epithelial cells, mesenchymal stem cells, mast cells, 
and endothelial cells. Lassus et al. reported elevated levels of IL-8 in the pseudocapsular 
tissue and synovial-like interface membrane in loosened THAs compared to controls 
[26]. Clarke et al. found statistically significant increases in the levels of IL-1β, IL-6, and 
IL-8 in synovial fluid from TJRs requiring revision due to aseptic loosening compared to 
patients undergoing primary TJR for OA [27]. IL-6 has also been identified as a potential 
biomarker in periprosthetic joint infection. One study noted significantly elevated levels 
of serum IL-6 in infected prosthetic joints when compared to aseptic joints undergoing 
revision surgery [28]. MCP-1 and MIP-3α have been identified as chemokines that are 
involved in the implant aseptic loosening pathology. Nakashima et al. observed MCP-1 
and MIP-3𝛼 expression in all tissue samples from failed arthroplasties, establishing their 
presence in the inflammatory cascade of arthroplasty failure [29]. They were also able to 
induce expression of MCP-1 by macrophages in cell culture after exposure to different 
types of wear particles. Because of the results identified in these studies, these eight 
cytokines were selected as cytokines of interest in the inflammatory process that may 
contribute to implant complications such as infection or aseptic loosening.  
 
 
Metal Ion Concentrations 
 
 Levels of cobalt, chromium, molybdenum, and titanium ions in the blood are 
frequently used as an indication of if there are metal components of an implant 
articulating against one another and causing pain and potentially other systemic problems 
in patients with a THA. In a study done by Savarino et al, cobalt, chromium, and 
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molybdenum ion levels were measured in patients in four groups: those with a metal on 
metal bearing, those with a metal on polyethylene bearing, those with osteoarthritis 
before implantation of a THA, and those with no systemic problems [30]. The values 
seen for cobalt levels in each of these groups, respectively, were 1.33 ng/ml, 0.64 ng/ml, 
0.36 ng/ml, and 0.24 ng/ml. For chromium, the values were 1.72 ng/ml, 0.60 ng/ml, 0.26 
ng/ml, and 0.25 ng/ml. Finally, for molybdenum, these values were 0.62 ng/ml, 0.62 
ng/ml, 0.42 ng/ml, and below detection limits for the group with no pathology. These 
values were consistent with other findings in literature. The same ions were tested for in 
this study and were compared to these values. In this study, the samples were analyzed at 
Brooks Applied Labs (Bothel, WA) and the results were sent in micrograms per liter 
(µg/L).  
 
 
Toxicology of Metal Ions 
 
 As mentioned previously, the ions of interest when studying orthopedic implants 
are mainly cobalt, chromium, and molybdenum, each of which have the capacity of affect 
the body in different ways. Cobalt has been shown to be cytotoxic and induce apoptosis 
at lower doses, and cause necrosis with an inflammatory response at higher doses in 
mammalian in vitro test systems. It is primarily accumulated in the liver, kidney, 
pancreas, and heart. The excretion of cobalt is initially rapid through the renal system 
over the first few days, but then slows and leads to significant long-term retention in the 
tissues for several years. In serum, the cobalt ions bind to binding sites on albumin, so 
therefore, the concentration of free cobalt ions is estimated to be only 5-12 percent of the 
total cobalt concentration in the body [31]. Because cobalt ions can bind to albumin, it 
can affect how it is distributed in the body. If the albumin concentrations in the body are 
low, less cobalt ions are able to bind to the binding sites on the albumin, leaving these 
cobalt ions free to interact with specific protein carriers with other cellular targets. These 
free cobalt ions can cause cobalt ion buildup in other tissues [32]. Studies have shown 
chromium to be cytotoxic as well, especially hexavalent chromium, which is considered 
grossly cytotoxic. Chromium can cause inhibited osteoblast-like cell metabolism, reduced 
phagocytic ability of polymorphonuclear leukocytes and murine macrophages, and can 
increase release of inflammatory mediators and cell death in macrophages. It has also 
been found that if more toxic elements such as chromium are selectively leached, this can 
lead to an increase in the toxicity of degradation products from the cobalt-chromium-
molybdenum alloy [33]. Additionally, in a study to observe how metal ions affect bone 
marrow stromal cells, chromium ions were found to be grossly cytotoxic, while cobalt, 
molybdenum, iron, and nickel ions were found to be moderately cytotoxic, and titanium, 
aluminum, vanadium, and manganese ions were found to be minimally cytotoxic [34]. 
There has been less research done on molybdenum’s cytotoxicity, however, one study 
that tested particles of pure metals in a mouse fibroblast cell line. While they found toxic 
effects of cobalt and chromium at several levels, toxicity of molybdenum was only seen 
at the highest concentration tested, 500 micrograms per milliliter [35]. 
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Objective and Hypothesis 
 
While total hip arthroplasty is one of the most common orthopaedic procedures 
performed today, there are very few implant retrieval studies being performed to assess 
these implants after implantation. Of the implant retrieval studies in existence, most are 
of failed implants retrieved at time of revision surgery, and very few are of well-
functioning implants at time of necropsy. The objective of this work was to study a few 
key factors such as taper dissociation force, polyethylene wear, taper corrosion, 
inflammatory cytokine content in synovial fluid, and metal ion content in the tissue to see 
if any of these factors may be indicative of implant survivorship. Another objective was 
to compare these parameters to one another and see what relationship existed between 
them, if any. A final objective is to use these as “baseline values” when completing the 
same tests on a group of failed implants in the future. To this end, the following 
hypotheses were tested: 
 
(a)  A negative relationship will exist between dissociation force and cytokine 
concentration. A higher dissociation force means that the taper connection is more 
intact, therefore, there is less corrosion and material loss in the taper connection 
and therefore less of an inflammatory response due to debris. However, it should 
be noted that cytokine concentrations are affected not only by metallic debris, but 
also by polyethylene debris, so an increase in cytokine concentrations could be 
due to either type of debris. Nonetheless, a negative association between 
dissociation force and cytokine concentration is expected in this study.  
 
(b)  A negative relationship will exist between dissociation force and corrosion. The 
tapers that are more highly-corroded will likely be experiencing more material 
loss on the trunnion and bore, and therefore, will have a lower dissociation force. 
The implants with less corrosion (minimal to mild) should have higher 
dissociation forces than those with more corrosion (moderate to severe), and the 
contacting surfaces have less corrosion and therefore material loss.  
 
(c)  A negative relationship will exist between metal ion content and dissociation 
force. As mentioned previously, a higher dissociation force means the taper 
connection is more intact, so there should be less corrosion and material loss at 
this site. Therefore, if there is less material being lost, the metal ion content will 
be lower.  
 
(d)  A positive relationship will exist between polyethylene wear and cytokine 
concentration. As the femoral head articulates against the polyethylene liner, 
debris are generated. In order to combat these debris, macrophages attempt to 
engulf the particles and often secrete inflammatory cytokines as a response. 
Therefore, a higher amount of wear on the polyethylene liner should result in a 
higher concentration of inflammatory cytokines.  
 
(e)  A positive relationship will exist between metal ion content and cytokine 
concentrations, specifically cobalt and titanium ion content. Similar to the 
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polyethylene and cytokine comparison, if there is more metal debris in the tissue, 
inflammatory cytokines will be released as macrophages are recruited to manage 
this debris. Cobalt has been found to increase IL-6 from osteoblast like cells[36, 
37]. Cobalt ions have also been shown to rapidly induced the protein secretion of 
IL-8 and MCP-1 in primary human osteoblasts[38]. Titanium has been shown to 
induce the differentiation of osteoclast precursors toward mature osteoclasts in 
about twenty percent of individuals[39]. While cobalt and titanium have been 
shown to increase cytokine activity, there have been no studies demonstrating this 
same phenomenon with chromium ion. Therefore, it is likely that no relationship 
will exist between chromium ion content and cytokine concentrations.  
 
(f)  Higher metal ion content will be seen in implants with higher corrosion due to 
material loss as mechanically assisted crevice corrosion occurs. Therefore, the 
implants with higher corrosion scores (moderate, severe) will have an increased 
concentration of metal ions compared to the implants with lower corrosion scores 
(minimal, mild).  
 
 
Equipment Used 
 
 
Instron 4505 Load Frame 
 
 An Instron 4505 Load Frame (Instron, Norwood, MA) was used for the 
mechanical head dissociation testing. This allows the stem of the implant to be pulled 
from the head of the implant at a precise rate and the resulting force to be measured. A 
custom mechanical test frame was created for this testing in the Implant Research Center 
at Drexel University (Philadelphia, PA), where the testing was completed (Figure 1-7).   
 
 
Fluoroscopy 
 
 Fluoroscopy was used prior to implant retrievals in order to assess the fixation of 
the implant, check for osteolysis, or bone loss around the implant surface thus verifying it 
is in fact a well-functioning implant, and to see if there were any screws or other parts in 
place to be aware of before beginning retrieval. The model used was the OrthoScan HD 
Model 1000-0001 (OrthoScan, Scottsdale, AZ). 
 
 
Calibrated Micrometer 
 
 A calibrated digital micrometer was used for linear polyethylene wear 
measurements. One side of the micrometer was placed on the back of the polyethylene 
and the other side was placed on the front in order to determine thickness at a particular  
location. The micrometer used is a Mitotoyo Digimatic Micrometer Series 293 MDC-MX 
Lite and measures to 0.001 millimeters (Mitotoyo, Aurora, IL). 
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Figure 1-7. Custom test frame for head dissociation testing, Drexel University 
 
(Personal communication from Genymphas Higgs on May 16, 2016) 
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Luminex Multiplexer 
 
 Multiplex assays were performed using the Luminex system. This platform 
enables simultaneous measurement of multiple proteins per well on a ninety-six well 
plate using very little sample (approximately thirty microliters per sample). This 
technology produces results comparable to ELISA assays but with higher efficiency and 
speed. It is also less expensive per target than ELISA. The multiplexer used was the 
Luminex MAGPIX (Luminex Corporation, Austin, TX).  
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CHAPTER 2.    METHODOLOGY 
 
 
Retrieval Methods 
 
 The total hip implants used in this study came from one of two sources: the 
Medical Education and Research Institute (Memphis, TN) or RestoreLifeUSA 
(Elizabethton, TN). Cadaver specimens of the hip and proximal femur were obtained 
from both institutes, and were frozen until retrieval could take place. Before retrieval, 
images were taken using fluoroscopy to see if there was any obvious osteolysis. During 
the retrieval, incisions were made in order to expose the tissue surrounding the bone 
where the implant was located. Tissue samples were obtained anterior, posterior, inferior, 
and superior to the acetabular cup, as well as from the taper itself. The tissue-implant 
interface was assessed as recommended by ASTM Standard F561-13. Figure 2-1 shows 
pictorially where the samples were obtained. Synovial fluid samples were aspirated from 
the joint and centrifuged at 1600 rpm for twenty minutes to remove cell particles, then 
kept frozen in a -80 degrees Celsius freezer. The implant was then removed from the 
bone as recommended by ASTM Standard F561-13, placed in biohazard bags, and 
shipped to Drexel University (Philadelphia, PA) for cleaning, wear scoring, and 
mechanical testing [40].  
 
 
Implant Cleaning 
 
The implants were cleaned using a method designed by Drexel University Implant 
Research Center in accordance with ASTM Standard F561-13 [40]. The implants were 
removed from packaging and biohazard bags and examined to ensure all parts were 
present. Inventory pictures were taken of the bag and all implant components, ensuring 
the implant number was visible. Each component was rinsed in cold water in a biohazard 
sink in order to remove any loose tissue. A 1:10 Discide:water solution was mixed in a 
mixing cup and the implants were placed in the solution for a twenty minute soak. 
Brushes were then used to remove remaining tissue from the implant while being careful 
not to scratch or damage the implant surface in any way. The Discide:water solution was 
then disposed of and a 1:10 bleach:water solution was created. The implants then 
completed another 20 minute soak, and brushes were again used to remove loose debris. 
At this point, the implant components were no longer considered biohazard and could be 
placed in a clean mixing cup. For ceramic components, the cleaning process ended here.  
 
 If the components were metallic, they were placed in a clean mixing cup and the 
cup was filled with water. These cups were then placed in an ultrasonicator for 25 
minutes, keeping the water level in the ultrasonicator the same as the water level in the 
mixing cups. The mixing cups and implants were then removed from the ultrasonicator, 
the water was drained and the cups were refilled and placed back in the ultrasonicator for 
another 25 minutes. The implants were then laid out on Versidry sheets overnight to air 
dry within the fume hood. The implants were then packaged in separate bags to avoid 
scratching one another and labeled to await testing and wear scoring.  
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Figure 2-1. Tissue sample locations 
 
Modified with permission.  
Foran, J.R.H. Total Hip Replacement. OrthoInfo 2015 8/2015 [cited 2016 8/18/16]. 
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Head Dissociation Testing 
 
 This testing was completed in accordance with ASTM Standard F2009-00, 
discussed previously. An Instron 4505 was used for the entirety of this testing procedure, 
following a Standard Operating Procedures document created by Drexel University. Load 
frame verification should be performed before any testing to ensure all components are 
working properly. A custom testing frame (Drexel University) was used for this testing to 
allow the head to be separated from the stem of the implant. This frame included 
specially designed head and stem plates that allowed the taper to be oriented vertically for 
the entirety of the testing. Before testing began, a 30 kN load cell was installed in the 
Instron, and calibration and balance of the load cell was completed on the Instron 
machine. 
 
 After calibration and balance was completed, the custom femoral stem and head 
fixtures were assembled into the crosshead of the Instron. The specimen was placed in 
the head fixture with the stem hanging downward. The crosshead was then raised until 
the stem entered the stem fixture. The crosshead was then raised slowly until there was 
only enough space between the head fixture and stem fixture for attachment of the stem 
plate. The load channel was set to zero to create a unique set point for each test sample, 
as samples masses may vary. The stem plate was then connected to the fixture using four 
bolts, ensuring no preload was exerted on the implant, and the crosshead was slowly 
lowered until the sample was oriented with the taper connection vertical. A small gap was 
left between the connection and stem plate to allow for a toe region in the data and to 
ensure no preload was present. The Instron then began moving the stem fixture down, 
away from the head fixture, at 0.05 mm/s, recording the resulting force continually. 
When the load suddenly dropped, the Instron recognized that the connection between the 
stem and head was broken and stopped displacement. The peak load was recorded as the 
force needed to dissociate the head and stem.  
 
 
Corrosion Scoring 
 
 For head corrosion scoring, a Goldberg Corrosion Classification was used [41]. 
The components of the implants were cleaned to ensure the damage that was seen was 
damage to the implant itself and not residue of any kind. Three scorers examined the 
implant components under a microscope and independently viewed the male and female 
taper components and scored them from 1 to 4, following the criteria shown in Table 2-1 
and looking for all signs of fretting or corrosive attacks. After each scorer had completed 
scoring of both components, the scorers reviewed the results together and discussed any 
discrepancies. The components with discrepancies were studied under microscopy again, 
and a final score was agreed upon by all three scorers.  
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Table 2-1. Criteria for taper corrosion scoring  
 
Damage Score Criteria 
Minimal 1 Fretting on < 10% of surface and no 
corrosion damage 
Mild 2 Fretting on > 10% of surface and/or 
corrosion attack confined to one or 
more small areas 
Moderate 3 Fretting > 30% and/or aggressive 
local corrosion attack with corrosion 
debris 
Severe 4 Damage over majority (> 50%) of 
mating surface with severe corrosion 
attack and abundant corrosion debris 
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Metal Ion Testing 
 
 Inductively Coupled Plasma Mass Spectrometry (ICP-MS) is an analytical 
technique used to make elemental determinations of a material. This method combines 
high-temperature ICP with a mass spectrometer. The ICP source converts the atoms of 
the elements in the associated sample to ions, which are then separated and able to be 
detected by a mass spectrometer. For this testing, tissue samples were taken from two 
locations: anterior and posterior to the acetabular cup. These samples were placed in 
fixative and sent to Drexel University for sample preparation and analysis.  
 
To prepare for the acid digestion of the tissue samples, the laboratory space and 
equipment was prepared by rinsing and soaking all tools in an acid solution consisting of 
five to ten percent trace metal nitric acid and eighteen mega-ohm ultrapure water 
overnight. This process included sample containers, the digest vessel, and any other 
equipment that would be in direct contact with the samples. Any minor tools involved in 
the process were washed twice and dried with Kimtech wipes. Once the laboratory space 
and equipment were prepared, the samples were cut to a 25 milligram size using a 
ceramic knife and plastic tweezers. Care was taken to ensure the samples did not contact 
any form of metal. A water bath was set to ninety-five degrees Celsius, and centrifuge 
tubes were labeled to identify the samples. The samples were then washed with eighteen 
mega-ohm ultrapure water to remove ethanol, and were placed in the correctly labeled 
tube. The acid solution was created by adding two milliliters of seventy percent trace 
metal grade nitric acid to each tube under a fume hood. Next, one milliliter of hydrogen 
peroxide was added to each tube followed by three milliliters of thirty-seven percent trace 
metal grade hydrochloric acid, also under the fume hood. Three samples of only acid 
solution were also prepared in three tubes with no tissue samples as blank samples. The 
hydrogen peroxide was allowed to react as the water bath heated to the correct 
temperature. Once heated, the tubes were placed in the water bath for a two-hour 
incubation period. After the two-hour period, the tubes were removed and placed in the 
fume hood for thirty minutes to cool. After the cooling period, an addition one milliliter 
of hydrogen peroxide was added to each tube and given thirty minutes to react. The tubes 
were then placed back into the water bath for an additional two-to-three-hour incubation 
period.  
 
The samples were then placed into labeled two milliliter micro-centrifuge tubes to 
be sent to Brooks Applied Labs (Bothell, WA). Each tube received one milliliter of the 
sample and acid mixture and one milliliter of eighteen mega-ohm ultrapure water. The 
remaining sample was diluted to a fifteen milliliter volume with the eighteen mega-ohm 
ultrapure water. The method for analysis used by Brooks Applied Labs was validated 
using the Luts-1 certified reference material from the National Research Council of 
Canada. This material is a solid biological matrix that contains certified quantities of 
cobalt and chromium.  
 
Once Brooks Applied Labs completes the analysis, the data was first checked to 
ensure the blank samples had low levels of metal. Any amount of metal in the blank 
sample was considered to be a contamination. If the contaminants were low in value and 
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consistent between the blanks, they were averaged and the average was subtracted from 
the remaining samples. This allows the final data to be represented without the 
background noise present due to uncontrollable contamination. The data was then 
reported in either micrograms per liter or parts per billion.  
 
 
Polyethylene Degradation 
 
 A Standard Operating Procedure from Drexel University was used for these 
measurements. The polyethylene liners were removed from the acetabular cups and 
rinsed to remove any debris present. Next, these liners were studied under a microscope 
to see if any machining lines could be seen. A marker was used to draw a border of where 
machining lines were present, and where they tended to be worn down. The area where 
the machining lines were worn was considered to be the superior side. A few 
measurements were taken using a Mitotoyo Digimatic Micrometer Series 293 MDC-MX 
Lite (Mitotoyo, Aurora, IL) to determine the thinnest area of the liner. This was marked 
with an “S” for superior and the opposite was marked with an “I” for inferior. Three 
measurements were taken from the superior side halfway up the polyethylene liner, and 
three measurements were taken from the inferior side, ensuring they were also made at 
the halfway point of the liner. These three measurements were averaged and the superior 
measurements were subtracted from the inferior, giving the total polyethylene linear 
wear. Although this measurement was called the wear, it should be noted that some of the 
decrease in thickness of the superior side could be due to creep, or deformation of the 
material due to high stresses. Unfortunately, this was not something that could 
necessarily be directly calculated so it was a noted area of weakness in our measurement.  
 
 
Inflammatory Cytokine Testing  
 
 The cadaveric cytokine samples were tested using the Luminex Multiplex Assay. 
A group of sixteen osteoarthritic samples were obtained with IRB approval from patients 
undergoing primary total hip arthroplasty to use as a comparison to the fourteen 
cadaveric samples. For the assay, the standards, calibrator diluent RD6-52, samples, and 
diluent RD2-1 were brought to room temperature. The Certificate of Analysis provided 
with the kit was followed in order to reconstitute each standard cocktail with RD6-52 
diluent. These were left under gentle agitation for 15 minutes prior to making dilutions. 
The RD6-52 diluent was used to dilute each sample by 2, using 80 microliters (µL) of 
sample and 80 µL of diluent, giving 160 µl of diluted sample in each tube. The standard 
cocktails were created according to directions in the booklet to create standards 1-6. The 
lights were turned off, and the microparticle cocktail was centrifuged for 30 seconds at 
1000 G. The cocktails were gently vortexed and then diluted with RD2-1. The standards 
and samples were then added to their corresponding wells and covered with a foil sealer, 
and incubated for two hours at room temperature on a microplate shaker. During this 
time, the wash buffer was created by adding 20 milliliters (mL) wash buffer concentrate 
to 480 mL deionized water. With the lights still off, a magnet was placed on the bottom 
of the microplate and the plate was shaken over sink to remove liquid. Each well was 
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filled with 100 µL of wash buffer which was then shaken out, and this was repeated two 
more times. The biotin antibody cocktail was then centrifuged and diluted with RD2-1. 
Each well received 50 µL of the diluted biotin cocktail and was incubated for 1 hour at 
800 rotations per minute (rpm) under a foil plate sealer. The streptavinin cocktail was 
then created by mixing 220 µL with 5.35 mL of wash buffer. The wells were washed 
with wash buffer three times, and then 50 µL of the streptavinin cocktail was added to 
each well. This was incubated for 30 minutes at room temperature at 800 rpm. The wells 
were then washed three times with wash buffer again. Finally, 100 µL of wash buffer was 
added to each well and incubated for two minutes at 800 rpm, and the plate was read on 
the magpix reader, with concentrations given in picograms per milliliter (pg/mL).  
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CHAPTER 3.    RESULTS 
 
 
Implant Information 
 
 There were a total of nineteen implants retrieved for this testing, but not all of the 
implants were able to undergo each type of testing, and the full implant information was 
not able to be obtained for all implants. In these nineteen implants, there were five with 
28 mm heads, five with 32 mm heads, four with 36 mm heads, and two with 40 mm 
heads. Fourteen of the acetabular liners were highly crosslinked polyethylene, and four 
were not highly crosslinked. Of the metal on polyethylene implants, nine had a cobalt 
chromium alloy head on a titanium alloy stem, and four had a cobalt chromium alloy 
head and stem. Two implants were ceramic heads on a titanium alloy stem. One of these 
heads was zirconia and the other was a zirconia alumina combination. Eight of the 
implants had a head taper angle of 12/14 and one had an angle of 16/18. None of the 
implants had cemented shells, and two had cemented stems. The manufacturer, design, 
and other implant characteristics can be seen in Table 3-1.  
 
 
Head Dissociation Testing 
 
 The dissociation forces in this study ranged from 1428 to 5368 Newtons, with a 
mean and standard deviation of 2790±1200 Newtons. The sample size for this testing was 
15 implants, with two of these having ceramic heads (16-03-730R and RLU0519169R). 
These results can be seen in Figure 3-1.  
 
 
Corrosion Scoring 
 
 As mentioned previously, the male and female tapers were each scored from 1 to 
4 based on the Goldberg Corrosion Classification. The scores for each portion of these 
implants can be seen in Table 3-2.   
 
 
Inflammatory Cytokine Testing 
 
 For the group of sixteen osteoarthritis control samples, eight cytokines were 
tested. They were IL-6, MCP-1, IL-1β, MIP-3α, M-CSF, IL-8, IL-2, and TNF-α. The 
values for IL-8, MCP-1, MIP-3α, and M-CSF were mostly in range for each sample, but 
most were very close to the lower limit of detection so were obviously not very active in 
the body. For TNF-α, only six of the sixteen samples were in the detectable range, and 
these samples were just above the lower limit of detection. For IL-6, seven of the sixteen 
samples were in the detectable range, with the other nine samples being above the limits 
of detection. For IL-2, nine of the sixteen samples were in the detectable range, with the 
other seven being below the lower limit of detection. For IL-1β, all sixteen samples were  
 
 29 
Table 3-1. Femoral component information 
 
Sample ID Design Manufacturer Head 
Material 
Head 
Size 
(mm) 
Taper 
Angle 
HXLPE Stem 
Material 
14-11-788R Duraloc Depuy CoCrMo 28 -- N -- 
16-03-730L Trilogy Zimmer CoCrMo 32 12/14 Y Ti6Al4V 
14-08-614L Reflection Smith and 
Nephew 
CoCrMo -- -- Y -- 
14-08-580L Reflection Smith and 
Nephew 
-- -- -- Y -- 
14-05-425L Trilogy Zimmer Metal 32 12/14 Y Ti6Al4V 
16-03-730R Richard 
Reflection 
Smith and 
Nephew 
White 
Zirconia 
28 -- N Ti6Al4V 
16-08-983R Trident Stryker CoCrMo 36 12/14 Y Ti6Al4V 
RLU1114149R Pinnacle Depuy CoCrMo 40 12/14 Y Ti6Al4V 
RLU0315169 L Trilogy Zimmer CoCrMo 28 12/14 Y CoCrMo 
15-10-288L Pinnacle Depuy CoCrMo 36  Y CoCrMo 
RLU0519169L Trilogy Zimmer CoCrMo 36 -- Y Ti6Al4V 
15-10-491R Trilogy Zimmer CoCrMo 36 12/14 Y CoCr 
14-12-835L Continuum Zimmer CoCrMo 32 12/14 Y Ti6Al4V 
15-08-338L Ringloc 
Constrained 
Biomet CoCrMo -- -- -- Ti6Al4V 
15-10-466L Pinnacle Depuy CoCrMo 32 -- Y CoCrMo 
RLU1029149R Richard 
Reflection 
Smith and 
Nephew 
CoCrMo 28 -- N Ti6Al4V 
14-12-835R Trilogy Zimmer CoCrMo 32 12/14 Y Ti6Al4V / 
TA 
RLU0519169R Trident Stryker Zirconia-
Toughened 
Alumina 
40 16/18 Y Ti6Al4V 
 
 30 
 
 
Figure 3-1. Graph of the dissociation force for each tested implant  
 
 
 
 
Table 3-2. Corrosion scores for male and female taper components 
 
Sample ID Corrosion Score 
 Female Male 
14-08-614L 2 1 
16-03-730R Ceramic 1 
15-10-491R 1 1 
RLU1114149C R 2 1 
15-10-466L 2 1 
RLU0315169B L 2 3 
14-12-835R 1 1 
14-12-835L 2 1 
15-10-288L 1 1 
14-08-580L 2 1 
RLU1029149C 1 1 
14-05-425L 2 1 
16-08-983R 1 1 
RLU0519169L 1 1 
RLU0519169R Ceramic 1 
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below the limits of detection. The cytokine concentrations for each sample can be seen in 
Table 3-3.  
 
For the group of fourteen cadaveric implants, the same eight cytokines were 
tested, but there were only five main cytokines of interest. These were IL-6, MCP-1, IL-
1β, MIP-3α, and M-CSF. The cytokine results for IL-8 were above the detection limits 
for nine out of the fourteen samples tested, meaning that there is likely IL-8 present in 
high amounts, though it is not quantifiable. For TNF-α, only five of the fourteen samples 
were in range, with the rest falling below the limits of detection. The five that were in 
range were very close to the lower limit of detection, making them essentially irrelevant. 
For IL-2, only four of the fourteen samples tested were in range, the rest falling below the 
limits of detection. Similarly to TNF-α, even the samples from these four samples that 
were in range were very close to the lower limit of detection. The cytokine concentrations 
for each sample can be seen in Table 3-4.   
 
 Mann Whitney tests were done between the two groups for each cytokine, and 
significant differences were seen between the groups for IL-8 (p <0.001), IL-1β 
(p<0.001), IL-1 (p=0.002), and M-CSF (p<0.001). However, this could be due to the fact 
that many of the values were on the very low end of detection for these groups, with one 
sample being elevated which could cause the differences to be seen. 
 
 
Linear Polyethylene Wear Measurements 
 
 Values for polyethylene wear measurements ranged from 0.040 to 1.867 
millimeters (mm). However, the value of 1.867 mm was found to be an outlier. The mean 
and standard deviation were 0.296±0.468 mm including this outlier, but decreased to 
0.184±0.215 mm excluding the outlier. These values can be seen in Table 3-5.  
 
 
ICP-MS 
 
 The samples were analyzed by Brooks Applied Labs (Bothell, WA) and results 
for cobalt, chromium, and titanium levels were obtained from the anterior and posterior 
tissue capsule in micrograms per liter (µg/L). These were averaged and are reported in 
Table 3-6 for every implant except 16-08-983R, as tissue samples were not obtained for 
this components. This table also includes the head and stem material for the implants to 
help interpret these results.  
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Table 3-3. Concentrations of inflammatory cytokines for osteoarthritis control 
specimens (pg/mL) 
 
Sample ID IL-6 MCP-1 IL-1B 
MIP-
3a 
M-CSF 
TNF-
α 
IL-8 IL-2 
002 >1180 350.84 <16.3 11.64 563.13 <8.9 8.53 35.86 
003 17.73 232.96 <16.3 8.85 <514 <8.9 6.80 <35 
004 804.15 391.40 <16.3 10.70 1104.00 <8.9 12.78 <35 
005 >1180 250.69 <16.3 13.56 1168.03 <8.9 11.18 <35 
006 44.60 342.23 <16.3 <7.9 742.55 <8.9 11.24 <35 
007 16.22 455.35 <16.3 9.77 1042.74 9.93 19.77 <35 
008 >1180 1613.10 <16.3 20.79 1050.52 9.43 137.66 47.89 
009 >1180 720.25 <16.3 14.04 1698.83 <8.9 58.71 37.24 
010 88.60 515.90 <16.3 44.08 1184.25 9.43 25.34 <35 
011 >1180 3210.13 <16.3 47.26 1018.99 9.18 >1140 43.48 
012 >1180 1254.41 <16.3 45.43 673.61 9.56 56.51 36.55 
013 >1180 923.25 <16.3 20.04 1578.72 <8.9 191.22 40.01 
014 174.07 389.67 <16.3 9.76 6050.69 <8.9 14.39 <35 
015 >1180 758.41 <16.3 14.55 <514 <8.9 33.72 36.55 
016 >1180 819.11 <16.3 12.61 703.08 <8.9 26.71 36.78 
017 1164.60 1605.89 <16.3 37.93 1234.53 <8.9 244.69 46.03 
Mean 808.12 864.60 <16.3 21.40 1415.26 9.37 124.95 40.04 
St. Dev. 524.48 768.205 - 14.42 1372.90 0.42 279.93 4.60 
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Table 3-4. Concentrations of inflammatory cytokines for cadaveric specimens 
(pg/mL) 
 
Sample ID IL-6 MCP-1 IL-1B 
MIP-
3a 
M-CSF 
TNF-
α 
IL-8 IL-2 
14-08-614L 702.97 <98 3724.40 11.73 73237.05 <8.9 >1140 <35 
16-03-730L 829.69 511.02 20.16 9.55 51918.99 <8.9 >1140 <35 
16-03-730R 735.44 2177.16 53.18 15.34 46051.50 <8.9 >1140 35.64 
15-10-491R 81.66 271.68 143.90 14.22 54057.49 9.78 >1140 <35 
RLU1114149C R >1180 >7940 485.56 >1920 32312.03 16.05 >1140 76.29 
15-10-466L 27.77 113.35 129.72 <7.9 52170.45 <8.9 284.82 <35 
15-08-338L 885.25 4243.78 45.43 122.22 33171.82 <8.9 >1140 <35 
RLU0315169B L 20.18 411.68 178.07 28.96 14963.88 <8.9 694.16 <35 
14-12-835R 91.31 286.65 70.96 8.53 62937.91 <8.9 >1140 <35 
14-12-835L 87.13 414.07 115.95 18.69 69956.68 <8.9 >1140 <35 
15-10-288L >1180 649.77 128.98 100.84 77613.82 9.78 >1140 <35 
RLU0519169L 102.86 489.24 63.06 20.55 34835.14 9.43 >1140 <35 
RLU0519169R 93.87 409.96 51.12 23.90 54334.86 8.93 >1140 <35 
Mean 433.71 1292.27 376.67 164.51 52054.13 <8.9 977.70 <35 
St. Dev. 456.11 2219.31 970.36 506.54 18336.89 - 340.18 - 
 
 
 
 
Table 3-5. Linear polyethylene wear measurements for each sample (mm) 
 
Sample ID 
Polyethylene Linear 
Wear (mm) 
14-08-614L 0.040 
16-03-730L 0.151 
16-03-730R 1.867 
15-10-491R 0.224 
RLU1114149C R 0.097 
15-10-466L 0.099 
RLU0315169B L 0.086 
14-12-835R 0.087 
15-10-288L 0.351 
14-08-580L 0.089 
RLU1029149C 0.909 
14-05-425L 0.111 
16-08-983R 0.071 
RLU0519169L 0.131 
RLU0519169R 0.126 
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Table 3-6. Cobalt, chromium, and titanium levels for implant (ppb or µg/L) and 
component material for each 
 
Sample ID 
Cobalt 
(ppb) 
Chromium 
(ppb) 
Titanium 
(ppb) 
Stem 
Material 
Head 
Material 
14-08-614L 0.2875 3.3730 0.0000 CoCr - 
16-03-730L 0.8030 8.0955 0.7548 CoCr Ti 
16-03-730R 2.3013 5.2407 0.0000 Zirconia Ti 
15-10-491R 1.3335 1.2918 0.0000 CoCr CoCr 
RLU1114149C 
R 4.4546 51.2542 1.9681 CoCr Ti 
15-10-466L 0.5363 24.5765 21.2185 CoCr CoCr 
15-08-338L 3.8725 4.8174 0.0000 CoCr Ti 
RLU0315169B 
L 1.1816 1.4999 0.0000 CoCr CoCr 
14-12-835R 0.3901 1.9043 269.5773 CoCr Ti 
14-12-835L 2.2751 44.4078 3.0290 CoCr Ti 
15-10-288L 3.6876 32.4262 0.0000 CoCr CoCr 
14-08-580L 0.5759 10.4695 2.2960 - - 
RLU1029149C 0.7221 1.4135 33.7643 CoCr Ti 
14-05-425L 7.8357 29.7613 0.0000 Metal Ti 
14-11-788R 576.0150 1960.2175 142.6086 CoCr Ti 
16-08-983R - - - CoCr Ti 
RLU0519169L 2.0000 185.5829 13.1055 CoCr Ti 
RLU0519169R 0.2637 4.4603 1.9699 Alumina Ti 
Mean 35.7962 139.4584 28.8407 - - 
St. Dev. 139.2254 471.2798 70.9989 - - 
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Testing Comparisons 
 
 
Dissociation Force versus Cytokine Concentrations (a) 
 
The concentrations of each of the relevant inflammatory cytokines were compared 
to the dissociation forces for each sample. Cytokine levels that were below the limits of 
detection were not included in these comparisons, however, those that were above the 
limits of detection were included, with their value being the maximum detectable limit. 
Direct comparisons were done between the two variables and a linear trendline was 
applied to determine how significant this correlation was. However, since no one in 
literature has used any specific trend to assign to this type of data, the variables were also 
ranked (one rank for dissociation force and one rank for cytokine concentrations) for each 
sample, and those ranks were plotted against one another to determine if there was any 
significance in these comparisons. The direct comparison and the ranked comparison for 
the five relevant inflammatory cytokines can be seen in Figures 3-2 through 3-11. The 
correlation coefficients, confidence interval for the correlation, and Pearson’s rank p-
values for each comparison can be seen in Tables 3-7 and 3-8, and the correlation 
coefficients and Pearson rank p-values once outliers were removed can be seen in Tables 
3-9 and 3-10.  
 
 
Dissociation Force versus Head Corrosion Scores (b) 
 
 The stem components of the implants, as shown previously in Table 3-1, were 
almost all given a score of 1 with one exception, being scored a 3. However, the head 
scores were fairly equally distributed between 1 and 2. Therefore, these were separated 
into two groups based on corrosion scores, and normality was assessed with a Shapiro-
Wilk test. The two groups were found to be normally distributed with equal variances, so  
a t-test was performed to see if there was a difference in dissociation force between the 
two groups. The p-value for this t-test was 0.6 with a power of 8%, meaning that while no 
significant difference could be detected, a low power makes us less likely to detect a 
difference when one does in fact exist.  
 
 
Dissociation Force versus Metal Ion Concentrations (c) 
 
 The dissociation force of each implant was compared to the cobalt, chromium, 
and titanium levels for each implant. There were eleven total samples for which 
dissociation forces as well as metal ion concentrations were able to be obtained. Direct 
comparisons were done between the two variables and a linear trend line was applied to 
assess the significance of the relationship. However, since nothing was found in literature 
applying any specific trend to assess this type of data, the variables were also ranked (one 
rank for the dissociation force and one rank for the metal ion levels) for each sample, and 
those ranks were plotted against each other to determine if there was any significance in 
these comparisons. The direct comparison and ranked comparison for each of the three  
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Figure 3-2. IL-6 concentration compared to the dissociation force 
 
 
 
 
 
 
Figure 3-3. IL-6 rank among all samples compared to the dissociation force rank 
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Figure 3-4. MCP-1 concentration compared to the dissociation force 
 
 
 
 
 
 
Figure 3-5. MCP-1 rank among all samples compared to the dissociation force 
rank 
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Figure 3-6. IL-1β concentration compared to the dissociation force 
 
 
 
 
 
 
Figure 3-7. IL-1β rank among all samples compared to the dissociation force rank 
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Figure 3-8. MIP-3α concentration compared to the dissociation force 
 
 
 
 
 
 
Figure 3-9. MIP-3α rank among all samples compared to the dissociation force 
rank 
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Figure 3-10. M-CSF concentration compared to the dissociation force 
 
 
 
 
 
 
Figure 3-11. M-CSF rank among all samples compared to the dissociation force 
rank 
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Table 3-7. Correlation coefficients and p-values for the direct comparison of 
each cytokine to its dissociation force 
 
Cytokine 
Sample 
Size 
Correlation 
Coefficient (r) 
95% Confidence 
Interval of r P-Value 
IL-6 12 0.32 -0.32 to 0.75 0.3 
MCP-1 10 0.64 0.01 to 0.90 0.05 
IL-1β 12 -.066 -0.62 to 0.53 0.8 
MIP-3α 10 0.67 0.069 to 0.91 0.03 
M-CSF 12 -0.37 -0.78 to 0.26 0.2 
 
 
 
 
Table 3-8. Correlation coefficients and p-values for the ranked comparison of 
each cytokine to its dissociation force 
 
Cytokine 
Sample 
Size 
Correlation 
Coefficient (r) 
95% Confidence 
Interval of r P-Value 
IL-6 12 0.44 -0.19 to 0.81 0.2 
MCP-1 10 0.30 -0.41 to 0.78 0.4 
IL-1β 12 0.23 -0.40 to 0.71 0.5 
MIP-3α 10 0.22 -0.47 to 0.75 0.5 
M-CSF 12 -0.26 -0.73 to 0.37 0.4 
 
 
 
 
Table 3-9. Correlation coefficients and p-values for the direct comparison of 
each cytokine to its dissociation force with outliers removed 
 
Cytokine 
Sample 
Size 
Correlation 
Coefficient (r) 
95% Confidence 
Interval of r P-Value 
IL-6 12 0.32 -0.32 to 0.75 0.3 
MCP-1 8 0.041 -0.68 to 0.72 0.9 
IL-1β 10 -0.14 -0.71 to 0.54 0.7 
MIP-3α 10 0.014 -0.62 to 0.64 0.9 
M-CSF 12 -0.37 -0.78 to 0.26 0.2 
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Table 3-10. Correlation coefficients and p-values for the ranked comparison of 
each cytokine to its dissociation force with outliers removed 
 
Cytokine 
Sample 
Size 
Correlation 
Coefficient (r) 
95% Confidence 
Interval of r P-Value 
IL-6 12 0.44 -0.19 to 0.81 0.2 
MCP-1 8 0.050 -0.68 to 0.73 0.9 
IL-1β 10 0.069 -0.59 to 0.67 0.9 
MIP-3α 10 -0.16 -0.72 to 0.52 0.7 
M-CSF 12 -0.26 -0.73 to 0.37 0.4 
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metal ions assessed can be seen in Figures 3-12 through 3-17. The correlation 
coefficients, confidence interval for the correlations, and Pearson rank p-values for each 
comparison can be seen in Tables 3-11 and 3-12.  
 
 
Linear Polyethylene Wear versus Cytokine Concentrations (d) 
 
 The concentrations of each of the relevant inflammatory cytokines was compared 
to the linear polyethylene wear measurements for each sample. Cytokine levels that were 
below the limits of detection were not included in these comparisons, however, those that 
were above the limits of detection were included, with their value being the maximum 
detectable limit. Direct comparisons were done between the two variables and a linear 
trendline was applied to determine how significant this correlation was. However, since 
nothing was found in literature applying any specific trend to assess this type of data, the 
variables were also ranked (one rank for the polyethylene wear and one rank for cytokine 
concentrations) for each sample, and those ranks were plotted against one another to 
determine if there was any significance in these comparisons. The direct comparison and 
the ranked comparison for the five relevant inflammatory cytokines can be seen in 
Figures 3-18 through 3-27. The correlation coefficients, confidence interval for the 
correlation, and Pearson rank p-values for each comparison can be seen in Tables 3-13 
and 3-14, and the correlation coefficients, confidence interval for the correlation, and 
Pearson Rank p-values once outliers were removed can be seen in Tables 3-15 and 3-16. 
 
 
Metal Ion Concentrations versus Cytokine Concentrations (e) 
 
The cytokine concentrations for the cytokines that had values within the limits of 
detection (IL-6, MCP-1, IL-1β, MIP-3α, and M-CSF) were compared to the cobalt, 
chromium, and titanium levels for each implant. There were thirteen samples for which 
the cytokine values and metal levels were available, except for MCP-1 in which there 
were only twelve available, due to one of the samples being below limits of detection for 
the cytokine. Direct comparisons were done between the two variables and a linear 
trendline was applied. The comparison of these two variables can be seen in Figures 3-28 
through 3-42, and the correlation coefficients, confidence interval for the correlation, and 
Pearson rank p-values for each comparison can be seen in Tables 3-17 through 3-19.  
 
 
Metal Ion Concentrations versus Corrosion Scores (f)  
 
 Because the levels of corrosion were so low in these samples, graphical 
representation did not give much insight into what relationships, if any, were evident. The 
samples were divided into two groups, those with a head corrosion of 1 and those with a 
head corrosion of 2, and a t-tests was completed between these two groups for each of the 
three metals. There were five samples in the group with corrosion scores of 1, and seven 
samples in the group with corrosion scores of 2. For cobalt, the Shapiro-Wilk normality  
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Figure 3-12. Dissociation force compared cobalt levels in tissue 
 
 
 
 
 
 
Figure 3-13. Dissociation force rank compared cobalt level in tissue rank  
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Figure 3-14. Dissociation force compared to chromium levels in tissue 
 
 
 
 
 
 
Figure 3-15. Dissociation force rank compared to chromium levels in tissue rank  
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Figure 3-16. Dissociation force compared to titanium levels in tissue 
 
 
 
 
 
 
Figure 3-17. Dissociation force rank compared to titanium levels in tissue rank  
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Table 3-11. Correlation coefficients and p-values for the direct comparison of 
each metal ion type to dissociation force 
 
Metal Sample Size 
Correlation 
Coefficient (r) 
95% 
Confidence 
Interval of r P-Value 
Cobalt 11 0.56 -0.062 to 0.87 0.07 
Chromium 11 0.66 0.11 to 0.90 0.03 
Titanium 11 -0.30 -0.76 to 0.37 0.4 
 
 
 
 
Table 3-12. Correlation coefficients and p-values for the ranked comparison of 
each metal ion type to its dissociation force 
 
Metal Sample Size 
Correlation 
Coefficient (r) 
95% 
Confidence 
Interval of r P-Value 
Cobalt 11 0.30 -0.36 to 0.76 0.4 
Chromium 11 0.21 -0.45 to 0.72 0.5 
Titanium 11 -0.14 -0.68 to 0.50 0.7 
 
 
 
 
 
 
Figure 3-18. IL-6 concentration compared to the polyethylene wear 
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Figure 3-19. IL-6 rank among all samples compared to the polyethylene wear rank 
 
 
 
 
 
 
Figure 3-20. MCP-1 concentration compared to the polyethylene wear 
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Figure 3-21. MCP-1 rank among all samples compared to the polyethylene wear 
rank 
 
 
 
 
 
 
Figure 3-22. IL-1β concentration compared to the polyethylene wear 
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Figure 3-23. IL-1β rank among all samples compared to the polyethylene wear 
rank 
 
 
 
 
 
 
Figure 3-24. MIP-3α concentration compared to the polyethylene wear 
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Figure 3-25. MIP-3α rank among all samples compared to the polyethylene wear 
rank 
 
 
 
 
 
 
Figure 3-26. M-CSF concentration compared to the polyethylene wear 
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Figure 3-27. M-CSF rank among all samples compared to the polyethylene wear 
rank 
 
 
 
 
Table 3-13. Correlation coefficients and p-values for the direct comparison of 
each cytokine to its polyethylene wear 
 
Cytokine 
Sample  
Size 
Correlation 
Coefficient (r) 
95% Confidence 
Interval of r 
P-
Value 
IL-6 11 0.25 -0.42 to 0.74 0.5 
MCP-1 10 0.094 -0.57 to 0.68 0.8 
IL-1β 11 -0.19 -0.71 to 0.47 0.6 
MIP-3α 10 -0.14 -0.71 to 0.54 0.7 
M-CSF 11 -0.017 -0.61 to 0.59 0.9 
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Table 3-14. Correlation coefficients and p-values for the ranked comparison of 
each cytokine to its polyethylene wear 
 
Cytokine 
Sample  
Size 
Correlation 
Coefficient (r) 
95% Confidence 
Interval of r 
P-
Value 
IL-6 11 0.37 -0.30 to 0.79 0.3 
MCP-1 10 0.31 -0.40 to 0.79 0.4 
IL-1β 11 -0.58 -0.88 to 0.027 0.06 
MIP-3α 10 0.091 -0.57 to 0.68 0.8 
M-CSF 11 0.063 -0.56 to 0.64 0.9 
 
 
 
 
Table 3-15. Correlation coefficients and p-values for the direct comparison of 
each cytokine to its polyethylene wear with outliers removed 
 
Cytokine 
Sample  
Size 
Correlation 
Coefficient (r) 
95% Confidence 
Interval of r 
P-
Value 
IL-6 11 0.25 -0.42 to 0.74 0.5 
MCP-1 8 0.57 -0.22 to 0.91 0.1 
IL-1β 9 -0.25 -0.79 to 0.49 0.5 
MIP-3α 8 -0.074 -0.74 to 0.67 0.9 
M-CSF 11 0.017 -0.59 to 0.61 0.9 
 
 
 
 
Table 3-16. Correlation coefficients and p-values for the ranked comparison of 
each cytokine to its polyethylene wear with outliers removed 
 
Cytokine 
Sample  
Size 
Correlation 
Coefficient (r) 
95% Confidence 
Interval of r 
P-
Value 
IL-6 11 0.37 -0.30 to 0.79 0.3 
MCP-1 8 0.39 -0.43 to 0.86 0.3 
IL-1β 9 -0.36 -0.83 to 0.40 0.3 
MIP-3α 8 0 -0.70 to 0.70 1.00 
M-CSF 11 0.063 -0.56 to 0.64 0.9 
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Figure 3-28. Cobalt levels in tissue compared to IL-6 levels in synovial fluid 
 
 
 
 
 
 
Figure 3-29. Chromium levels in tissue compared to IL-6 levels in synovial fluid 
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Figure 3-30. Titanium levels in tissue compared to IL-6 levels in synovial fluid 
 
 
 
 
 
 
Figure 3-31. Cobalt levels in tissue compared to MCP-1 levels in synovial fluid 
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Figure 3-32. Chromium levels in tissue compared to MCP-1 levels in synovial fluid 
 
 
 
 
 
 
Figure 3-33. Titanium levels in tissue compared to MCP-1 levels in synovial fluid 
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Figure 3-34. Cobalt levels in tissue compared to IL-1β levels in synovial fluid 
 
 
 
 
 
 
Figure 3-35. Chromium levels in tissue compared to IL-1β levels in synovial fluid 
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Figure 3-36. Titanium levels in tissue compared to IL-1β levels in synovial fluid 
 
 
 
 
 
 
Figure 3-37. Cobalt levels in tissue compared to MIP-3α levels in synovial fluid 
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Figure 3-38. Chromium levels in tissue compared to MIP-3α levels in synovial fluid 
 
 
 
 
 
 
Figure 3-39. Titanium levels in tissue compared to MIP-3α levels in synovial fluid 
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Figure 3-40. Cobalt levels in tissue compared to M-CSF levels in synovial fluid 
 
 
 
 
 
 
Figure 3-41. Chromium levels in tissue compared to M-CSF levels in synovial fluid 
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Figure 3-42. Titanium levels in tissue compared to M-CSF levels in synovial fluid 
 
 
 
 
Table 3-17. Correlation coefficients and p-values for comparison between 
cytokines and cobalt levels 
 
Cytokine 
Sample 
Size 
Correlation 
Coefficient (r) 
95% Confidence 
Interval of r P-Value 
IL-6 13 0.67 0.19 to 0.89 0.01 
MCP-1 12 0.76 0.33 to 0.93 0.004 
IL-1B 13 -0.25 -0.71 to 0.35 0.4 
MIP-3a 13 0.60 0.031 to 0.87 0.04 
M-CSF 13 -0.22 -0.69 to 0.38 0.5 
 
 
 
 
Table 3-18. Correlation coefficients and p-values for comparison between 
cytokines and chromium levels 
 
Cytokine 
Sample 
 Size 
Correlation 
Coefficient (r) 
95% Confidence 
Interval of r P-Value 
IL-6 13 -0.11 -0.62 to 0.47 0.7 
MCP-1 12 0.025 -0.56 to 0.59 0.9 
IL-1B 13 -0.14 -0.64 to 0.45 0.7 
MIP-3a 13 0.13 -0.45 to 0.64 0.7 
M-CSF 13 -0.19 -0.67 to 0.40 0.5 
R² = 0.0389
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Table 3-19. Correlation coefficients and p-values for comparison between 
cytokines and titanium levels 
 
Cytokine 
Sample 
Size 
Correlation 
Coefficient (r) 
95% Confidence 
Interval of r P-Value 
IL-6 13 -0.28 -0.72 to 0.32 0.4 
MCP-1 12 -0.18 -0.68 to 0.44 0.6 
IL-1B 13 -0.11 -0.63 to 0.47 0.7 
MIP-3a 13 -0.11 -0.62 to 0.47 0.7 
M-CSF 13 0.20 -0.40 to 0.67 0.5 
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test did not pass, so a Mann-Whitney Rank Sum test was performed to determine if there 
was a significant difference between the two groups. The p-value for this test was 0.6, 
meaning that a statistically significant difference was not able to be determined. For 
chromium, the normality test also failed, and the Mann-Whitney Rank Sum test showed 
similar results, a p-value of 0.5. Therefore, a significant relationship could not be 
confirmed. A Mann-Whitney Rank Sum test was also performed for titanium, as it was 
also non-normal. This test gave a p-value of 0.8, so there was no statistically significant 
relationship between these groups either.  
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CHAPTER 4.    DISCUSSION 
 
 
Summary 
 
 Because the implants studied in these groups were known to be well-functioning 
with no loosening present, the hypothesis was that there would be low amounts of wear 
and damage, along with low inflammatory cytokine values and metal ion levels. This 
hypothesis was confirmed, as these implants all had minimal or mild corrosion, low 
inflammatory cytokine concentrations overall, and relatively low polyethylene wear, 
although this study did not allow a wear rate to be calculated. It is difficult to say whether 
metal ion content was on the lower end or not, as there are very few studies looking at 
metal ion levels in tissue through ICP-MS (most of the known levels are in serum). 
Although the levels of most of these factors were expected to be low, the hope was a 
relationship could be established between dissociation force and cytokine concentrations, 
dissociation force and metal ion concentrations, polyethylene wear and cytokine 
concentrations, metal ion concentrations and cytokine concentrations. There was also 
expected to be a difference in dissociation force and metal ion content at different levels 
of corrosion, with dissociation force decreasing as corrosion increased, and metal ion 
content increasing as corrosion increased. One hypothesis was that a negative relationship 
would exist between dissociation forces and inflammatory cytokine concentrations, 
because a higher dissociation force should mean the connection is more intact, therefore, 
there should be less metallic debris and less of an inflammatory response. Two cytokines 
had moderate positive correlations to the dissociation force (MCP-1: r=0.64, CI: 0.011 to 
0.90; MIP-3α: r=0.67, CI: 0.069 to 0.91), however, these were more due to one data point 
pulling the trend in a positive direction, as seen by the wide confidence intervals. A 
second hypothesis was that a positive relationship would exist between polyethylene 
wear and cytokine values because as polyethylene debris are released, monocytes and 
macrophages secrete cytokines to help manage the polyethylene debris. However, in this 
study, there were no strong correlations for any of the comparisons between cytokines 
and polyethylene wear. Another hypothesis was that a positive relationship would exist 
between cobalt and titanium and some inflammatory cytokines (specifically IL-6, MCP-
1, TNF-α, IL-8). The concentrations of TNF-α and IL-8 were not within range to allow 
for comparison of these cytokines to any other factors. Nothing in literature suggested a 
relationship between chromium and inflammatory cytokines. In this study, there was no 
meaningful correlation between titanium or chromium and any cytokines, as these 
comparisons all had very low correlation coefficients. However, when looking at cobalt, 
meaningful relationships seemed to emerge for IL-6 (r=0.67, CI: 0.19 to 0.89), MCP-1 
(r=0.758, CI: 0.326 to 0.928), and MIP-3α (r=0.60, CI: 0.066 to 0.86). The relationship 
between cobalt and IL-6 and MCP-1 was not surprising based on other findings in 
literature, but it is typically not associated with a change in MIP-3α. The confidence 
intervals seem to show some promise for a positive relationship between cobalt and 
MCP-1 and IL-6, but the lower end of the confidence interval for MIP-3α is almost zero, 
meaning a relationship between these two factors seems less likely. A fourth hypothesis 
was that the relationship between the metal ions and dissociation forces would be 
negatively related, but a moderate positive correlation was seen for cobalt (r=0.59, CI: -
 65 
0.062 to 0.87) and chromium (r=0.66, CI: 0.11 to 0.90). Although this is opposite of what 
was hypothesized, there seems to be one data point in each of these comparisons that is 
pulling the trend line to be as moderately positive as it is. The confidence interval for 
cobalt and dissociation force includes zero. More research should be done to include 
implants with varying degrees of corrosion and varying dissociation forces in order to 
make any meaningful conclusions about these comparisons. Finally, there was no 
detectable difference in metal ion content or dissociation forces between minimally and 
mildly corroded implants. A difference may have been able to be detected with a broader 
spread of corrosion, but with such low corrosion being seen in these implants, no 
difference was able to be detected.  
 
The fact that this study contained well-functioning implants with low levels of 
damage and inflammatory cytokine content made it difficult to identify potential 
relationships, as the cytokine values were mostly the same for each sample, while the 
other factors such as dissociation force and polyethylene wear were more variable. While 
this factor made it difficult to identify potential relationships, these values were also very 
preliminary with only fourteen samples. As more samples are added, the hope is that 
more defined relationships will emerge for each of these comparisons. While this study 
did not necessarily provide meaningful information about how these values are related to 
one another, it is a step in the right direction for understanding what makes certain 
implants work well. There is a lack of retrieval studies on well-functioning implants, and 
therefore it is difficult to establish baseline values for comparison when looking at failed 
implants. This study will be continued with the addition of these failed implants in the 
future, and this will hopefully help to solve some of the mystery around what factors lead 
to implant failures, and what factors are crucial for their success. 
 
 
Inflammatory Cytokine Concentrations 
 
 The two groups assessed for the inflammatory cytokine testing were an 
osteoarthritis control group (sample size of 16) and a well-functioning cadaveric implant 
group (sample size of 14). Values were expected to be on the lower end of the detectable 
range of the cytokine concentrations for each of these groups. These low levels were 
expected for the osteoarthritis control group because the cytokines selected were mostly 
associated with the body’s response to wear debris that may contribute to bone 
resorption, and since the samples in this group did not have an implant yet in the joint of 
interest, the concentrations of many of these were expected to be low. In the cadaveric 
implant group, the values were expected to be low because, again, the cytokines selected 
were cytokines that are known to contribute to the RANK/RANKL pathway that can lead 
to aseptic loosening, and fluoroscopic images of these implants showed there was no 
aseptic loosening present in the joint. Bone cement particles can also cause an 
inflammatory response leading to higher concentrations of these cytokines, but none of 
these implants had cemented acetabular cups, and only two implants had cemented 
femoral stems, so the bone cement debris is not considered to play a major role in the 
cytokine concentrations. While there were a few samples in each group with slightly 
elevated values of one particular cytokine, as a whole, these values were very close to the 
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lower limit of detection. This makes it difficult to establish any meaningful correlations 
with these values, as there is not a good spread of the data across the entire detection 
range, however, it does create a good “baseline value” for use with comparing with 
groups of revision or failed total hip arthroplasty.  
 
For TNF-α, the osteoarthritis group had only five out of the sixteen within range. 
The mean of these five was 9.37 pg/ml. The cadaveric implant group had only five of the 
fourteen within range, and the mean of these five was 10.8 pg/ml. The detection limits for 
TNF-α ranges from 8.9-2170 pg/ml, so the means of these two groups are only barely 
within detection limits, and therefore it can be concluded that TNF-α was not present in 
meaningful concentration in either group. This is not surprising for a couple of reasons. 
For one, as mentioned earlier, elevated levels of any of these cytokines were not 
expected. Secondly, the half-life of TNF-α is very low, only around five to eight minutes 
[42]. There have been studies addressing TNF-α in revision arthroplasties, however, most 
of these are obtaining a number of cells containing TNF-α in the tissue surrounding the 
implant, not assessing the levels of TNF-α in synovial fluid. Therefore, a direct 
comparison of the levels obtained in this study to levels of failed implants in literature is 
difficult.  
 
 For IL-6, the osteoarthritis group had seven of the sixteen samples within range, 
with the remaining nine being above the limit of detection. The mean for the 
concentrations for this group was 808 pg/ml. For the cadaveric implant group, twelve of 
the fourteen samples were within range with the remaining two samples being above the 
limits of detection. The mean of the group was 433 pg/ml. The detectable range of IL-6 is 
4.9-1180 pg/ml. This particular cytokine was more elevated in the osteoarthritis group 
than it was in the cadaveric group, but this difference was not found to be significant 
when using a Mann Whitney test. Values for the half-life of IL-6 are found to have a 
range in literature, with one study reporting a value of about 103 minutes [43]. The levels 
of this particular cytokine are intriguing, because unlike the majority of the cytokines, 
this one is actually relatively elevated. IL-6 is known to be secreted by osteoblasts to 
induce osteoclast formation, so it is interesting that it would be slightly elevated in the 
groups in which there was no implant present (osteoarthritis) or in which there is an 
implant with no sign of aseptic loosening (well-functioning implant group). This cytokine 
has also been shown in literature to be related to periprosthetic joint infections, in which 
there would be inflammation present to try to remove the infection [28]. This cytokine 
was shown to be elevated in the serum of total joint revisions, but an exact level was not 
given [44]. Because the cytokine was more elevated in the osteoarthritis group, it may be 
interesting to further study whether or not this cytokine may play a role in the body’s 
response to osteoarthritis in a joint.  
 
For IL-8, the osteoarthritis group had fifteen out of the sixteen samples in range, 
with one above the limits of detection. This one sample drove the mean of the group up to 
124 pg/ml, but without this sample, the mean of the group was only 57 pg/ml. However, 
for the cadaveric implant group, eleven out of the fourteen were above the limits of 
detection, with the mean of this group being 977 pg/ml. The detectable range of this 
group is 4.7-1140 pg/ml. For this cytokine, the cadaveric group was significantly more 
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elevated than seen in the osteoarthritis control group, with a p-value of less than 0.001 
when using a Mann Whitney test to compare. While this cytokine was almost non-
existent in the osteoarthritis group, it was very close to the upper limit of detection for the 
cadaveric group. This cytokine, similarly to IL-6 is known to play a role in osteolysis and 
aseptic loosening. Studies found elevated levels of IL-8 in total joint replacements 
undergoing revision when compared to primary replacements for OA [27]. However, this 
study did not include well-functioning implants at time of death, so it is difficult to say 
whether these results of elevated IL-8 in the cadaver group are abnormal. Because these 
joints have been checked with fluoroscopy for aseptic loosening and no signs of 
loosening were seen, this cytokine may play a role in the healing mechanisms that is 
unrelated to aseptic loosening. The production of IL-8 is known to be enhanced by TNF-
α, IL-1, and IL-3 [45], however, the levels of IL-1 and TNF-α in this study was relatively 
low. More work should be done to determine potential causes for elevated IL-8 that are 
unrelated to aseptic loosening.   
 
For MCP-1, all sixteen of the osteoarthritis samples were within range with a 
mean of 864 pg/ml. For the cadaver samples, eleven out of fourteen of the samples were 
within range with a mean of 1493 pg/ml. The range of this cytokine is 98-7940 pg/ml, so 
these means are on the lower end of this range. There was no detectable difference 
between these two groups. While there is no recorded half-life for MCP-1 in literature, 
MCP-1’s role is to recruit macrophages to a site when needed, as monocytes, which 
mature into macrophages, are thought to leave circulation by about 340 million each day 
[46]. Because the detectable limit of this cytokine goes up to 7940 pg/ml, a mean value of 
1493 pg/ml is considered to still be relatively low. While it is not statistically different 
than the mean of the levels in the osteoarthritis group, a reason it could have a slightly 
higher mean is that, while these are well-functioning implants, wear debris are still being 
produced in the joint daily. As these are being produced, monocytes are recruited to the 
joint to engulf and phagocytize these debris. Therefore, it would be expected for some 
level of MCP-1 to be present in any joint that has a joint replacement. This cytokine may 
be related to aseptic loosening in cases where there is so much wear debris present, the 
macrophages are unable to keep up with the demand and bone resorption begins to take 
place. However, that was not the case in the groups tested in this study.  
 
For IL-1β, all sixteen of the osteoarthritis samples were below detectable limits, 
so no mean could be obtained, but all fourteen of the cadaveric samples were in range 
with a mean of 376. Although the samples were within range, the detectable range for IL-
1β is 16.3-3950 pg/ml, so a mean of 376 is, again, very low on the detection range. IL-1β 
is a key mediator of the inflammatory response, and is essential for host response to 
pathogens. It is known to exacerbate damage during chronic disease and acute tissue 
injury. IL-1β is also known to have a very short half-life, although an exact value could 
not be found in literature [47]. Because of this short half-life, it is difficult to say whether 
or not the levels seen in the cadaveric group may have been higher initially. However, 
because these implants were known to be well-functioning, IL-1β would not need to be 
secreted in high amounts because there was no acute tissue injury. This cytokine would 
be expected to be high at the time of implantation, as there is severe tissue injury and 
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healing that must take place, but as the body adapts to the implant being present in the 
joint, the need for IL-1β secretion would be low.  
 
For MIP-3α, the osteoarthritis group had fifteen out of sixteen samples within 
range, with a mean of 21 pg/ml. The cadaveric group had eleven out of fourteen within 
range. One of these was above detection, while the other two were below detection. The 
mean of this group was 191, but if the sample above detection is excluded, the mean 
drops to 34. With a detectable range for MIP-3α of 7.9-1920 pg/ml, neither group had 
significant concentrations of this cytokine in the synovial fluid. There was no significant 
difference found between these two groups. Similarly to MCP-1, literature cites a short 
half-life for chemokines such as MIP-3α, but an exact number is not given [48]. 
Literature does not specifically address how MIP-3α relates to aseptic loosening, but it is 
known to be a cytokine that is strongly chemotactic to lymphocytes and is produced by 
osteoclast cells. It may potentially play a role in aseptic loosening by recruiting 
lymphocytes in response to polyethylene debris, and contributing to the RANKL pathway 
leading to osteoclastogenesis and bone loss. However, because it has not been studied in 
this particular application before, there are no values in literature about levels of MIP-3α 
in total joint replacements. More work should be done to determine what type of role this 
cytokine plays in aseptic loosening.   
 
For IL-2, the osteoarthritis group had seven out of sixteen samples below 
detection, with a mean of 40 pg/ml. The cadaver group had ten out of the fourteen 
samples below the limit of detection, with a mean of 42 pg/ml. The limits of detection for 
IL-2 are 35-8510 pg/ml, so these means are extremely low, so IL-2 is essentially 
negligible in these two sample groups. There is no statistical difference between the two 
groups. These values are very low, which is not unexpected because IL-2 has a half-life 
of 3.7 minutes [49]. Because this cytokine has such a short half-life, the values obtained 
in this study do not give much information. In order to get valuable and accurate 
concentrations for this cytokine, synovial fluid would need to be aspirated and frozen 
almost immediately after death for the cadaveric groups. The synovial fluid is spun for 
twenty minutes after obtaining it and before freezing it, which gives time for the levels to 
decrease dramatically. Therefore, from a practicality standpoint, this cytokine may not be 
the most useful for this application.  
 
Finally, for M-CSF, the osteoarthritis group had two out of sixteen samples below 
the limit of detection with a mean of 1372 pg/ml. The cadaver group had all fourteen 
samples within range with a mean of 52054 pg/ml. The limits of detection for M-CSF are 
514-124810 pg/ml, so these are still fairly low considering the full range of the cytokine. 
The differences between these two groups were found to be significant, with a p-value of 
<0.001 after completing a Mann-Whitney test. While studies have shown that this 
cytokine is present in revision cases and contributes to the RANKL pathway for aseptic 
loosening, this observation has typically been made by observing that there is M-CSF 
present in the cells of the tissue, so these results cannot be directly compared to the 
results of this study [50]. A study by Takei reported higher M-CSF levels in the fluid of 
loose hip joints when compared to mild OA, but this study did not test M-CSF levels in 
joints that had no problems evident [51]. While this cytokine was significantly higher in 
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the cadaver group compared to the OA group, it is still only at a level that is one-fifth the 
upper limit of detection. This cytokine is responsible for influencing hematopoietic stem 
cells to differentiate into macrophages or similar cell types, so it would be expected to be 
at least slightly elevated in the cadaver group, as some wear debris is always being 
produced and macrophages need to be recruited to assist with that. However, in a group 
of revision failed implants, these values would be expected to be much higher, as the 
larger amount of wear debris would necessitate more macrophages to be present. M-CSF 
is critical for osteoclast differentiation and is known to enhance osteoclast survival, so in 
joints where aseptic loosening is present, this cytokine may play a crucial role [52]. 
 
Although there were significant differences seen between the two groups for IL-8, 
IL-1β, IL-2, and M-CSF, the limitations of these need to be taken into considerations. 
Each of these groups had low sample sizes, fourteen in the cadaver group and sixteen in 
the osteoarthritis group. In some cases, one sample in a group has elevated concentrations 
of a particular cytokine not seen in the other samples. As a result, the mean is driven 
slightly upward causing a difference to be seen between the groups. If Tables 3-2 and 3-3 
are studied, one can observe that most of the cytokines concentrations are fairly close to 
one another on the low end of detection, and therefore, are not considered to be 
contributing to inflammation in a meaningful way. However, the numbers will be useful 
moving forward into revision and failure studies for hip implants as a baseline value for 
comparison.   
 
 
Corrosion Scores 
 
 As mentioned previously, the corrosion scores were very low for the retrieved 
implants. There were sixteen retrieved implants that the corrosion scoring was completed 
for. For the male portion of the taper, fifteen out of the sixteen implants received a 
corrosion score of 1, with the other implant receiving a score of 3. Therefore, these 
particular numbers were not useful in creating a correlation from male taper damage to 
any of the other factors studied. However, for the female portion of the taper, eight of the 
sixteen implants were scored a 2, six of the sixteen implants were scored a 1, and the 
remaining two were ceramic heads. Therefore, these were split into two groups to see if a 
difference could be detected in the dissociation forces between the implants with a head 
score of 1 and the implants with a head score of 2. However, the Shapiro Wilk test 
showed no detectable difference. This is understandable, because even though the 
implants were characterized with two different corrosion scores, the scores are 
representative of minimal (1) and mild (2) damage, and the scoring system continues up 
to moderate (3) and severe (4). The implants in this group were well-functioning implants 
in which problems were not seen in the patient before death, and therefore, these low 
damage scores are detected. A difference in the dissociation forces may have been seen 
between groups with a broader range of corrosion scores, for example, comparing 
minimal and severe, however, with these components being so slightly damaged, it is not 
unexpected that there was no detectable difference in dissociation forces here. It should 
be noted that there were different taper designs in this study. There are eight tapers that 
are known to be a 12/14 type taper, and one that was a 16/18 type taper. Because there 
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were not significant samples with different taper types, no conclusions can be drawn 
about which taper designs may be more prone to corrosion than others.  
 
 
Polyethylene Wear Measurements 
 
The polyethylene wear measurements were only able to take into account how 
much wear was present in linear thickness loss, and could not consider the causes of the 
loss or produce a rate. The average polyethylene wear was 0.296 mm when including the 
outlier of 1.867 mm, but dropped to 0.184 mm when excluding this outlier. 
Unfortunately, one weakness in this measurement is that a wear rate cannot be 
determined since there is no year of implantation for these implants. Therefore, the 
measurements must be taken as standalone values of how much polyethylene has been 
worn down, and cannot conclude anything about the frequency or mechanism that led to 
the wear. The reported wear rate for highly cross-lined polyethylene is reported to be 
very low, between 0.00 and 0.01 mm/year in the first three years, with no wear rates 
higher than 0.1 mm/year in one study [53]. Another study reported a mean linear 
polyethylene rate of 0.11 mm/year, with a range of 0-0.86 mm/year [54]. The average 
polyethylene wear was 0.184 mm for this study, and although it is unknown how long the 
implants were in place before death, this seems to be a relatively low amount of wear 
considering averages reported around 0-0.1 mm/year. Therefore, as assumed with these 
well-functioning prostheses, relatively low wear is present. Apart from knowing a 
specific wear rate, one factor that could aid in better understanding these results would be 
to know the mechanism of wear. This factor will be assessed in the future by noting 
damage scores on the femoral heads, as well as seeing if particular modes of damage are 
evident in the polyethylene liners. Another thing to consider when studying polyethylene 
wear is the head size of the implant. In this study, five implants had 28 mm heads, five 
implants had 32 mm heads, four implants had 36 mm heads, and two implants had 40 mm 
heads. Of these implants, linear wear measurements were obtained for three liners of 
implants with 28 mm heads, four liners of implants with 32 mm heads, four liners of 
implants with 36 mm heads, and two liners of implants with 40 mm heads. The mean of 
each of these groups were 0.954 mm (28 mm), 0.112 mm (32 mm), 0.193 mm (36 mm), 
and 0.114 mm (40 mm). This shows the highest wear was seen in the implants with the 
smallest head size, which is conflicting with what is shown in literature. However, the 
fact remains that the implantation time for these implants is unknown, and it is difficult to 
compare means of groups with such small sample sizes, between two and four implants 
per group. However, it is important to note that the head sizes of these implants can affect 
the polyethylene wear rates, and this should be tracked moving forward.  
 
 
ICP-MS Analysis 
 
 The values obtained in this study were much higher than what was seen in 
literature, however, these values are difficult to find in literature, and the values that are 
found are typically reported from serum. To this date, no values were found in literature 
studying the cobalt, chromium, and titanium levels in the tissue surrounding total hip 
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implants. In the study by Savarino et al mentioned in the introduction, the levels for 
cobalt and chromium in patients with a metal on polyethylene bearings were 0.64 µg/L 
and 0.60 µg/L, respectively, however, these were the values from the patient’s serum. In 
this study, because the values were obtained by analysis of the anterior and posterior 
capsular tissue, the results were expected to be higher because the metal debris remains in 
the localized area instead of being diluted throughout the body, as in serum. In this study, 
the average value seen for cobalt was 35.80 µg/L, for chromium was 139.46 µg/L, and 
for titanium was 28.84 µg/L. The full set of results can be seen in Table 3-6. Out of the 
seventeen samples metal ion levels were able to be obtained for, nine had a cobalt 
chromium/titanium taper combination, four had a cobalt chromium/cobalt chromium 
taper combination, two were a ceramic/titanium taper combination, and two did not have 
the metal bearing types available at this time. While only four of the implants in this 
study did not include titanium as a metal, seven of the implants had a titanium level of 0. 
While the cobalt and chromium levels were low for several of the samples, they did not 
have any values of 0, while seven of the samples had titanium values of 0. One potential 
reason for this is the “blank” samples used in the analysis actually had an average 
titanium value of 8.4 µg/L. The levels of each ion for the blanks was subtracted from the 
reported value, so this could mean there were samples with very low values of titanium 
that may have been overlooked due to background noise in the samples. Another reason 
could be, as mentioned before, since these are well-functioning implants, values could be 
low. The corrosion scores for the stems of almost all the implants were 1, except for one 
implant which was scored a 3. This low corrosion seen in the stems of the samples could 
also explain the low titanium ion levels seen in the samples. This relationship will be 
further explored in the sections comparing metal ion levels to other factors.  
 
 
Dissociation Force versus Cytokine Concentrations (a) 
 
The hypothesis for this comparison was that as dissociation force increased, 
cytokine concentration would decrease, as a higher dissociation force should mean the 
taper connection is more intact. Therefore, there is less corrosion and material loss in the 
taper connection and hopefully less of an inflammatory response to debris. However, it 
should be noted that cytokine concentrations may go up due to polyethylene debris as 
well. When comparing the dissociation force for each implant to the various cytokine 
concentrations and trying to determine if any correlations exist, two different methods 
were used. These were simply compared number-to-number (the cytokine concentrations 
to the dissociation force) to look for correlations, as well as rank-to-rank, in which the 
rank for each individual implant’s dissociation force and cytokine concentration amongst 
the group was used. This was done in an attempt to standardize the numbers. However, 
because these were well-functioning implants and the cytokines were mostly clustered 
around the lower limit of detection, it was difficult to ascertain any meaningful 
correlations. With a broader spread of cytokine concentrations, a better conclusion may 
have been able to be drawn about how these factors relate. As it is, there were only two p-
values considered to be significant (<0.05) when looking at these comparisons. The first 
was found when the concentration of MCP-1 was directly compared to the dissociation 
force of the implants, and this produced a p-value of 0.05. MCP-1 is the main chemokine 
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responsible for recruiting monocytes. These monocytes can then mature into 
macrophages, which are the main scavenger cells of the immune system that attempt to 
find and phagocytize foreign bodies. This comparison gave a positive correlation of 0.64, 
which is contrary to what was hypothesized. It is believed that a higher dissociation force 
means that the taper connection should be more intact, meaning less wear debris is being 
produced and therefore the need for monocytes to assist in removal of wear debris is 
lower. However, this belief will be further explored when directly comparing the 
cytokine concentrations to the metal ion content in the tissue. One reason this positive 
correlation could be seen is that when looking at the graph in Figure 3-4, there is one 
data point that seems to be pulling the graph in a positive direction. The confidence 
interval for the correlation coefficient for this comparison was 0.011 to 0.90. Therefore, 
while the correlation between these two variables was moderate (0.64), the 95% 
confidence interval states that the actual correlation coefficient could fall anywhere from 
0.011 to 0.90 with 95% confidence. This is likely due to the fact that there is a low 
sample size in this comparison, with one value that is much different than the others 
pulling the trend in a more positive direction. This data point was considered to be an 
outlier for the MCP-1 concentrations, and when it was removed, the p-value for this 
comparison increased to 0.9. Based on the 95% confidence interval and low p-value 
when outliers are removed, it is not possible to say with certainty what the relationship 
between these two factors is. In order to see a relevant comparison between these two 
factors, the sample size of the group would need to be increased, and a wider spread of 
cytokines would be necessary. The second significant correlation was the direct linear 
comparison of the concentration of MIP-3α to the dissociation force of the implants, 
producing a p-value of 0.03. MIP-3α is a cytokine that is strongly chemotactic to 
lymphocytes. These lymphocytes can play a role in the RANK/RANKL pathway which 
can lead to bone resorption, which is why it is relevant in this application. Similarly to 
MCP-1, a negative correlation was hypothesized to be seen for this, but instead a positive 
correlation of 0.67 was seen. However, when a 95% confidence interval was completed 
for the correlation coefficient, a range of 0.069 to 0.91 was found to be the interval. 
Similarly to MCP-1, there were two data points that pulled the trend line in the strong 
positive direction, which is likely why there was a higher correlation coefficient between 
these factors. Because the confidence interval again goes from almost 0 to almost 1, it is 
difficult to confidently state any relationship between these two variables based on the 
data, as there is 95% confidence that the true correlation coefficient could fall anywhere 
within that range. There were two outliers in this comparison as well that, when removed, 
increased the p-value to 0.9. Therefore, again, a larger sample size would be needed with 
a better spread of data points in order to say anything conclusive about this correlation. 
With outliers removed, this correlation does not appear to have any significance. The 
remainder of the correlation coefficients for the comparisons ranged from 0.066 to 0.44, 
which did not produce any significant p-values and had wide confidence intervals for the 
correlation coefficients. This was not surprising, because, as mentioned previously, the 
cytokine values were so low on the limits of detection, the spread of the data makes it 
difficult to see any correlations.  
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Dissociation Force versus Corrosion Scoring (b) 
 
 The hypothesis for this comparison was that implants that were more highly 
corroded would have a lower dissociation force due to material loss than those implants 
with less corrosion. Unfortunately, for this study, this hypothesis was not able to be tested 
thoroughly, as the implants in this study were minimally corroded. For the trunnion, all 
implants except one had a corrosion score of 1, or minimal. For the bores, all implants 
were scored either a 1, minimal, or 2, mild. There was no significant difference in 
dissociation forces between these two groups. In order to better explore this hypothesis, a 
broader spread of corrosion scores would be needed.  
 
 
Dissociation Force versus Metal Ion Concentrations (c) 
 
 Positive relationships were seen for the comparisons of cobalt and chromium 
levels in tissue to the dissociation forces of the implants, and a very slight negative 
relationship was seen for the comparison of titanium levels in the tissue to the 
dissociation forces of the implants. The titanium relationship is affected by the fact that 
five out of the eleven samples had a titanium value of zero, so a relationship may be 
difficult to determine, as well as the fact that there is one titanium value significantly 
more elevated than the rest. Upon further analysis, this value was found to be an outlier. 
When directly comparing the cobalt levels to the dissociation forces, a p-value of 0.07 
was seen, and when directly comparing the chromium levels to the dissociation forces, a 
p-value of 0.03 was seen. While this seems to suggest a promising relationship between 
these factors, it must also be noted that these values are obtained by using a Pearson -rank 
coefficient, which assumes a linear relationship between the two variables. Because this 
relationship has not been explored in literature, it is difficult to definitively say that this 
relationship would be linear, however, it is a step in the right direction for future 
exploration of this relationship down the road. A positive relationship was contrary to 
what was hypothesized, because as micromotion at the articulation of the head and neck 
of the implant occurs, the oxide layer can be broken down which leads to the release of 
these metal ions. This can also lead to the corrosion of the surfaces, which can decrease 
the strength of the taper connection. Therefore, higher concentrations of these metals 
were expected to lead to a decrease in the dissociation force. However, when the 
confidence interval of the correlation coefficient of each of these comparisons is 
calculated, the positive relationship seems less likely. The confidence interval for the 
correlation coefficient of the comparison of cobalt and dissociation force includes zero   
(-0.062 to 0.87), which means that there is 95% confidence that the true correlation 
coefficient falls anywhere within that range. The confidence interval for the correlation 
coefficient of the comparison of chromium and dissociation force is 0.11 to 0.90. 
Therefore, it cannot be confidently concluded that there is a positive relationship between 
the presence of these metal ions and dissociation force, but it does seem to have slightly 
more of a relationship than cobalt. There have been some studies with preliminary data 
showing that more metal debris and therefore more corrosion can lead to a higher 
dissociation force because of the increase in friction between the two surfaces, however, 
this is for severely corroded implants and does not necessarily apply to this data set that 
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only experienced minimal and mild corrosion. A broader set of implants with more 
varying dissociation forces and corrosion forces may give more insight into this 
relationship. One flaw in this comparison other than the wide confidence intervals that 
could explain why the relationship is contrary to what is hypothesized could be that there 
are other factors that contribute to the dissociation force that are unable to be controlled 
in this study. For one, the assembly of the taper has been shown to greatly influence the 
strength of the taper connection. For example, the force of the impaction of the head onto 
the stem, the number of impactions, and whether the surfaces were wet or dry has been 
shown to impact this taper strength. Because these cannot be controlled for, the 
dissociation force must simply be taken as-is.   
 
 
Linear Polyethylene Wear versus Cytokine Concentrations (d) 
 
 For this comparison, the linear polyethylene and cytokine values were both 
directly compared, as well as ranked amongst all the samples and compared. For these 
comparisons, no significant p-values were seen. There was one value approaching 
significance (considered to be 0.05) when comparing the rank of IL-1β to the rank of the 
linear polyethylene wear. The correlation was -0.58 with a p-value of 0.06. Similarly to 
the two correlations seen previously when comparing the dissociation forces, this 
correlation is opposite of what was hypothesized. A positive correlation was expected to 
be seen when comparing polyethylene wear an IL-1β, because as polyethylene debris is 
generated, macrophages attempting to engulf the debris secrete IL-1β in response. 
However, the cytokine concentrations for IL-1β were all very close to the lower limit of 
detection. The mean for these cytokines was 16.3-3950 pg/ml, and the average of these 
samples was 376 pg/ml. Therefore, without a larger spread of cytokine values and with 
such a small sample size, it is uncertain whether this negative trend would continue as the 
sample size expands. This significance was also only seen in the ranked comparison 
between the two groups. The direct comparison had a p-value of 0.6, so it is difficult to 
say confidently that this negative correlation exists and is significant. In addition, there 
was one outlier in the IL-1β concentrations, and when this outlier was removed, the p-
value for this comparison increased to 0.3, so the closeness to significance was, as 
expected, most likely due to an outlier. Finally, when looking at the confidence interval 
for the correlation coefficient for this data, it ranges from -0.88 to 0.027. Because this 
confidence interval includes 0, it is difficult to confidently state a relationship between 
these two variables based on this data. Based on this data alone, the correlation 
coefficient could fall anywhere between -0.88 and 0.027 with 95% confidence. As with 
the other comparisons in this study, more samples are needed in order to begin to solidify 
if any of these relationships do actually exist.  
 
 
Metal Ion Concentrations versus Cytokine Concentrations (e) 
 
 There were very few significant correlation between the cytokine concentrations 
and metal ion levels. Chromium and titanium did not have any p-values below 0.4 for any 
of the cytokines tested in this study. This was not surprising for chromium, as there is 
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very little discussion in literature about a relationship between the presence of chromium 
ions and an increase in the concentration of any inflammatory cytokines, however, 
literature does show titanium may increase concentrations of IL-6, IL-8, MCP-1, and 
TNF-α. While there were no promising results in this study suggesting a relationship 
between chromium and titanium with the inflammatory cytokines tested, there were 
several cytokines that seemed to show some promise in their relationships when 
compared to cobalt. There was a positive relationship between cobalt and IL-6, with a 
correlation coefficient of 0.67 and a p-value of 0.01. The 95% confidence interval for the 
correlation coefficient of this comparison was 0.19 to 0.89. There was also a positive 
correlation between cobalt and MCP-1, with a correlation coefficient of 0.76 and a p-
value of 0.004. The 95% confidence interval for the correlation coefficient of this 
comparison was 0.33 to 0.93. Finally, there was a positive relationship between cobalt 
and MIP-3α with a correlation coefficient of 0.60 and p-value of 0.04. The 95% 
confidence interval for the correlation coefficient of this comparison was 0.031 to 0.87. 
The remaining two cytokines had p-values of 0.4 and 0.5 for cobalt. It is interesting that 
some distinct relationships emerge when observing cobalt with several of the cytokines, 
but not titanium or chromium. In this study, the titanium levels were zero in almost half 
of the samples, which could explain the lack of relationships able to be detected. 
However, the mean level of chromium was 139 ppb while cobalt’s was 36 ppb, which 
means there should have been enough chromium present to detect the emergence of 
relationships between it and the cytokines. Cobalt and chromium also had the same 
number of samples plotted against the cytokine values, so the sample size should not be 
the main impactor of the lack of relationship. Because cobalt and chromium are both 
found together in a CoCrMo alloy, more research should be done to observe why cobalt 
seems to be having a stronger impact on the presence of inflammatory cytokines than 
chromium does. This does match with what is found in literature, as there are very few 
studies describing chromium impacting the levels of any inflammatory cytokines. It may 
also be interesting to intentionally seek out cytokines that are known to be affected by 
cobalt specifically, or chromium specifically, and note if relationships emerge with those 
cytokines. However, based on these results, it seems that cobalt is the metal that 
contributes more to the release of inflammatory cytokines, therefore may be the metal 
that contributes more to the inflammatory response to metallic debris. There is 
information in literature supporting the positive relationship seen between cobalt and IL- 
and MCP-1, but there is not anything showing it to have a relationship to MIP-3α. When 
looking at the confidence intervals for these three comparisons, the lower end of the 
confidence interval of cobalt with IL-6 was a correlation coefficient of 0.19, which is a 
mild correlation. The lower end of the confidence interval for the comparison of cobalt 
and MCP-1 was 0.33, suggesting a moderate correlation even at the worst-case end of the 
95% confidence interval. However, the confidence interval for the correlation coefficient 
of the comparison between cobalt and MIP-3α had a very wide range, with its lower end 
being almost zero (0.031). This is not surprising, as when looking at the graph of this 
comparison, (Figure 3-37), there seems to be one data point pulling the trend line in the 
positive direction, while the rest of the points seem to lie relatively flat. Based on this, the 
wide range for the confidence interval is not surprising. Based on the data compiled from 
this study, it does seem likely that the presence of cobalt ions has an effect on the 
 76 
concentrations of IL-6 and MCP-1 in the body. More research should be done to further 
explore the extent of this relationship.  
 
 
Metal Ion Concentrations versus Corrosion Scores (f) 
 
  When comparing the metal ion levels between the minimally corroded and mildly 
corroded head groups, there were no statistically significant differences between the 
groups. This lack of significance is not surprising, because there were so few samples in 
each group, and the corrosion levels between groups considered a one and those 
considered a two would be fairly close. Similarly to the results between dissociation 
forces and corrosion scores, it would be interesting to compare these levels in a group 
considered minimally corroded against a severely corroded group to see if differences in 
the metal levels of the tissues emerge.  
 
 
Limitations 
 
 The first limitation that has already been mentioned is the fact that the sample size 
for this study is very low. While there were a total of nineteen implants in the study, they 
were not all used for each portion of the study. Only fourteen of these contained enough 
synovial fluid to test for inflammatory cytokines. Eighteen were able to be analyzed 
through ICP-MS for metal ion content. Fifteen were able to be disassembled in order to 
obtain a dissociation force for the implant. Sixteen were able to be scored for corrosion. 
Fifteen were able to have the linear polyethylene wear tested. Therefore, most of the 
comparisons between types of testing are limited to a sample size of fourteen due to the 
inflammatory cytokine sample limitations. While everything was done to ensure as many 
samples as possible were obtained, the study was limited by the number of cadavers 
containing hip implants that could be obtained from our partner organizations (MERI and 
Restore Life USA).  
 
 A second limitation, which has also already been mentioned in the discussion for 
inflammatory cytokines, is that because these implants were well-functioning with no 
signs of osteolysis, the cytokine values were very low. While not unexpected, this 
limitation makes it difficult to draw meaningful conclusions when comparing with other 
types of testing. A similar limitation was also seen with corrosion scoring, because again, 
since the implants were well functioning and not damaged, the corrosion seen in the 
groups was low. Therefore, the corrosion values were not very revealing about how 
levels of corrosion relate to the other factors measured because only minimal and mild 
corrosion values were seen. A similar issue was observed in the detection of metal ion 
levels. While cobalt and chromium levels were able to be detected, the titanium levels 
observed were very low, with nine samples having titanium levels of zero and most of the 
other samples fairly close to zero. Only five samples had titanium levels higher than 10 
ppb. This could link back to the low corrosion on the stems of the implants, and also the 
fact that some of the implants had a cobalt chromium-cobalt chromium taper connection. 
While this is a noted limitation, it is also a necessary one. This study is functioning on 
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well-functioning implants, and as such, the implants in the group will be minimally 
damaged with a minimal negative reaction in the body. This study will be beneficial 
moving forward into the testing of failed and damaged implants, because it gives a 
baseline of values for a group of implants that will be functioning as expected. However, 
it is important to continue to build on the number of implants in this group in order to 
have a more meaningful sample size, which will hopefully allow for significant 
conclusions to be drawn moving forward.  
 
 Thirdly, the polyethylene wear measurements are just that, a singular 
measurement. As the duration of implantation is not known for this group of implants, a 
specific wear rate was unable to be calculated. Therefore, this number must be taken as 
is. A better polyethylene measurement as far as correlation goes would be to compare the 
wear rate to whatever factor it is being compared with, as it somewhat standardizes the 
polyethylene wear values. As it stands now, the values are all being treated as equal, 
when in reality, some of the implants with higher polyethylene values could be from 
twenty years ago, while some of the implants with lower values could have been fairly 
recent. This factor adds an element of uncertainty into any comparisons we make using 
polyethylene. This could also explain why no significance was shown when comparing 
the cytokine values to the amount of polyethylene wear. When adding a group of 
damaged implants in the future, wear rates should be used if possible.  
 
 Finally, a significant limitation in this study is the differences in the types of 
implants. Because there are many different designs, alloy combinations, and taper 
designs, it is not possible to state anything conclusively about which types may perform 
better than others, as the sample sizes of each group are too small. In this study, there 
were six Zimmer Trilogy, one Depuy Duraloc, four Smith & Nephew Reflection, two 
Stryker Trident, one Zimmer Continuum, one Biomet Ringloc Constrained, and three 
Depuy Pinnacle implants. There were also eight implants with a CoCrMo/Ti6AlV4 taper 
combination, four with a CoCrMo/CoCrMo taper combination, and two with a 
ceramic/Ti6AlV4 taper combination. There were eight implants with a 12/14 taper and 
one implant with a 16/18 taper. Finally, there were four implants with a 28 mm head, five 
with a 32 mm head, four with a 36 mm head, and two with a 40 mm head. With so many 
different variables present, and such small sample sizes of each type, these must just be 
taken as one large group of implants as they cannot be broken down into groups. 
Therefore, it must be noted, that the results from this study are results from a variety of 
designs and metal combinations. In order for conclusions to be drawn in the future about 
how each of these factors may impact implant function, large sample sizes in each of the 
groups would need to be gathered and results analyzed for each group.   
 
 
Future Work 
 
 As mentioned previously, the focus moving forward will be to continue the same 
types of testing explained in this study with a group of failed implants from patients 
undergoing a total hip revision surgery. Institutional Review Board approval has been 
obtained to begin collection of such devices, but there are not yet enough samples to 
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begin analysis of this type of data. The implants studied for the purposes of this thesis 
will hopefully aid in understanding the values obtained through the testing of the failed 
devices by providing a baseline of values seen in successful devices. The end goal is to 
see if there are any biological factors that may be indicative of problems with total hip 
implants that may lead to failure. While nothing definitive about the relationships 
between the numerous variables affecting the success of total hip implants can be 
concluded from this study, it is a step in the right direction for better understanding what 
causes implants to fail.  
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